{"study_id": 101474, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore novel approaches and emerging targets, including RAGE (receptor for advanced glycation end products) signaling blockade, for treating diabetes mellitus and cardiovascular disease.", "results_summary": "The abstract suggests that blocking RAGE signaling holds potential as a new therapy for diabetes and cardiovascular disease, alongside other emerging treatments like GLP-1 RAs and SGLT-2 inhibitors.", "population_specificity": "People with types 1 or 2 diabetes mellitus and cardiovascular disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:31.424494+00:00"}
{"study_id": 101468, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between Advanced Glycation End Products (AGEs) generated during food processing and their potential role in obesity and non-communicable diseases (NCDs) via gut microbiota disruption.", "results_summary": "The study suggests that AGEs, along with other processed food features, may negatively impact gut microbiota and contribute to western ailments like obesity and NCDs, though the exact mechanism (direct or indirect) requires further investigation.", "population_specificity": "General discussion of western dietary patterns, no specific population studied.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:31.972477+00:00"}
{"study_id": 101475, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent literature on biochemical/cellular targets, including Advanced Glycation End Products, for treating diabetic microvascular diseases.", "results_summary": "The abstract highlights that Advanced Glycation End Products are associated with mitochondrial dysfunction and diabetic microvascular complications, but it does not provide specific efficacy results for interventions targeting them.", "population_specificity": "Individuals with diabetes experiencing microvascular complications.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:32.179485+00:00"}
{"study_id": 101472, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the expression patterns of RAGE and SOX2 in benign and malignant prostate samples to assess their potential as prognostic markers or therapeutic targets.", "results_summary": "RAGE and SOX2 expression was significantly higher in prostate cancer lesions compared to prostatitis and benign prostatic hyperplasia, with a stepwise increase from lower to higher Gleason grades, suggesting their role in cancer progression.", "population_specificity": "87 prostatic biopsy samples (16 prostatitis, 20 benign prostatic hyperplasia, 51 prostate cancer).", "effective_dosage": "Not available", "study_duration": "Not applicable (cross-sectional study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:32.231316+00:00"}
{"study_id": 101469, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the relationship between the receptor for advanced glycation end-products (RAGE) and obstructive airways disease secondary to environmental exposure.", "results_summary": "The study found that RAGE is a mediator of inflammation associated with obstructive airways disease, with soluble RAGE potentially offering protective effects in some pulmonary processes. The review highlighted RAGE's biological relevance in environmental exposure-associated lung disease.", "population_specificity": "Human research studies focusing on pulmonary endpoints related to environmental exposure (e.g., particulate matter, cigarette smoke).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:32.259665+00:00"}
{"study_id": 101473, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the impact of hyperglycemia on immune cells, including the role of advanced glycation end products (AGEs) in immune cell metabolic reprogramming and their downstream signaling effects.", "results_summary": "The abstract discusses that hyperglycemia leads to the formation of AGEs, which affect immune cell function and may influence the efficacy of cell-based immunotherapies in type 1 diabetes mellitus. It highlights the importance of tight glucose control for patients undergoing such therapies.", "population_specificity": "Patients with type 1 diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:32.469977+00:00"}
{"study_id": 101471, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in osteoarthritis progression, particularly their involvement in inflammation and cartilage degradation through TLR signaling pathways.", "results_summary": "The study found that AGEs contribute to osteoarthritis progression by integrating into TLR signaling networks, exacerbating inflammation and cartilage destruction. High glucose levels and fatty acids further amplify these pro-inflammatory pathways, suggesting AGEs as a potential therapeutic target.", "population_specificity": "Not specified (general discussion of osteoarthritis mechanisms).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:32.535293+00:00"}
{"study_id": 101470, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of RAGE and its ligands in neurovascular and neurodegenerative disorders, focusing on mechanisms and potential therapeutic targets.", "results_summary": "The study found that RAGE ligand accumulation in aging and diabetes triggers CNS dysfunction, including endothelial dysfunction, reduced cerebral blood flow, and blood-brain barrier permeability, amplifying cellular stress. It also highlights RAGE's role in neurovascular perturbation and discusses potential therapeutic interventions.", "population_specificity": "Not specified (general discussion of CNS-related disorders, aging, and diabetes).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:32.985436+00:00"}
{"study_id": 101477, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in cancer initiation and progression, including their formation, reduction strategies, and interaction with RAGE.", "results_summary": "The study highlights that AGEs, when accumulated in tissues, increase inflammation, which is associated with cancer development. It discusses AGE formation, reduction strategies, and their interaction with RAGE in cancer progression.", "population_specificity": "Not specified (general discussion of AGEs in cancer tissues).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:40.734621+00:00"}
{"study_id": 101481, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the effects of phenolic compounds (PC) on reducing risk factors for cardiovascular diseases, including their potential mechanisms of action related to advanced glycation end products (AGEs).", "results_summary": "The study found that phenolic compounds may reduce platelet activity, exhibit anti-inflammatory effects, and protect against oxidation, thereby lowering LDL and AGEs formation. Preclinical and clinical evidence supports these physiological effects, with some health claims approved by regulatory agencies.", "population_specificity": "Elderly individuals (60 years and older) with multimorbidity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:41.716644+00:00"}
{"study_id": 101482, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compile data on tannins and their beneficial effects in managing diabetic complications, including those related to Advanced Glycation End Products (AGEs).", "results_summary": "The review found that tannins, such as gallic acid, ellagic acid, and catechin, can help control diabetes and its complications by targeting molecular pathways involved in disease progression. These compounds may serve as leads for developing cost-effective therapies.", "population_specificity": "Adults with diabetes and its complications (e.g., nephropathy, neuropathy, retinopathy, cardiomyopathy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:41.742948+00:00"}
{"study_id": 101483, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential link between hyperglycemia-associated AGEs formation and their role in diabetic complications and cancer risk.", "results_summary": "The study highlights that AGEs are implicated in diabetes complications and suggests a potential connection between hyperglycemia-associated AGEs and increased cancer risk in diabetic patients. It also discusses the potential of anti-glycation compounds to mitigate these risks.", "population_specificity": "Patients with diabetes and potential cancer risk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:42.114129+00:00"}
{"study_id": 101476, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the role of sirtuin-1 in the pathogenesis of diabetic nephropathy (DN) and its potential as a therapeutic target, including its interaction with advanced glycation end products (AGEs).", "results_summary": "The study found that upregulation of sirtuin-1 attenuates DN in experimental models and renal cells exposed to high glucose or AGEs, by modulating metabolic homeostasis, autophagy, apoptosis, oxidative stress, and inflammation. Some microRNAs targeting sirtuin-1 were implicated in DN progression, and synthetic/natural compounds enhancing sirtuin-1 activity showed protective effects.", "population_specificity": "Experimental models of diabetes and renal cells (podocytes, mesangial cells, renal proximal tubular cells).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:43.081526+00:00"}
{"study_id": 101478, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of moderate versus high load resistance training on tendon mechanical properties and matrix components, including advanced glycation end-products (AGEs), in older adults.", "results_summary": "The study found that tendon fluorescence (a measure of AGEs) was unaffected by either moderate or heavy load resistance training. Heavy load training maintained tendon mechanical properties, but this effect was unrelated to changes in major matrix components, including AGEs.", "population_specificity": "17 women and 19 men, aged 62-70 years.", "effective_dosage": "Not specified (training load magnitudes: heavy vs. moderate resistance training).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:43.550904+00:00"}
{"study_id": 101480, "supplement_id": 857, "safety_score": "30", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to summarize current evidence on dietary sources of AGEs, their absorption, and their role in reshaping gut microbiota, while highlighting health implications and knowledge gaps.", "results_summary": "The study found that dietary AGEs, formed during high-temperature cooking, may negatively impact health and gut microbiota, but evidence on their effects is conflicting, possibly due to alternate compounds formed during food processing.", "population_specificity": "Not specified (general dietary context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:48.913443+00:00"}
{"study_id": 101479, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the role of RAGE and its ligands, including Advanced Glycation End Products (AGEs), in skeletal biology and assess their potential as diagnostic or therapeutic targets in bone disease.", "results_summary": "The study found that RAGE and its ligands, including AGEs, have dual roles in bone homeostasis\u2014low levels may promote osteoblast function and fracture healing, while elevated levels are linked to bone loss and fragility. High levels of AGEs and other RAGE ligands induce osteoblast/osteocyte apoptosis and stimulate osteoclast activity, contributing to bone resorption.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:50.517999+00:00"}
{"study_id": 101484, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of glyceraldehyde-derived advanced glycation end products (glycer-AGEs) in stimulating asymmetric dimethylarginine (ADMA) generation, which is linked to endothelial dysfunction and cardiovascular risk.", "results_summary": "The study found that glycer-AGEs stimulate ADMA generation, which is an inhibitor of nitric oxide synthase and a predictor of cardiovascular events in patients with risk factors like diabetes and hypertension. This suggests a potential mechanism by which glycer-AGEs may contribute to cardiovascular disease.", "population_specificity": "Patients with coronary risk factors, such as diabetes and hypertension.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:50.663807+00:00"}
{"study_id": 101488, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the molecular mechanisms of diabetic cardiomyopathy (DCM), including the role of advanced glycation end products, and evaluate the therapeutic potential of EGCG against DCM.", "results_summary": "The abstract highlights that advanced glycation end products contribute to DCM pathogenesis, and EGCG shows therapeutic potential in mitigating these effects, supported by in vitro and in vivo studies.", "population_specificity": "Diabetic patients with or at risk of diabetic cardiomyopathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:52.209971+00:00"}
{"study_id": 101486, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of Advanced Glycation End Products (AGEs) in coronary artery disease (CAD) pathophysiology and explore therapeutic interventions targeting AGE reduction and AGE-RAGE signaling.", "results_summary": "The study found that AGEs are critical biomarkers for CAD development, interacting with RAGE to cause endothelial injury, vascular dysfunction, and altered platelet activity. It also highlighted AGEs' role in stent restenosis and discussed emerging therapies targeting AGE-RAGE signaling with potential clinical benefits.", "population_specificity": "Adult diabetic and non-diabetic subjects with coronary artery disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:52.365485+00:00"}
{"study_id": 101485, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether brief stress-management interventions (CBT or RT) could reduce s100A8/A9 levels, a RAGE-associated ligand, during primary treatment for breast cancer.", "results_summary": "Participants assigned to CBT or RT showed significant decreases in s100A8/A9 levels over 12 months compared to the health education control group, suggesting these interventions may reduce inflammation linked to RAGE signaling.", "population_specificity": "Postsurgical breast cancer patients (stage 0-IIIB), mean age 54.81 \u00b1 9.63 years.", "effective_dosage": "Not specified (intervention duration: 5 weeks).", "study_duration": "12 months (follow-up after 5-week intervention).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:52.470279+00:00"}
{"study_id": 101487, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to test the efficacy and tolerability of a mixture of vitamin E and hydroxytyrosol (HXT) in improving oxidative stress parameters and liver steatosis in adolescents with NAFLD.", "results_summary": "The treatment with HXT and vitamin E reduced insulin resistance, triglyceride levels, oxidative stress parameters, and steatosis grade, with steatosis improvement correlating with levels of advanced glycation end products and carbonylated proteins.", "population_specificity": "Adolescents with biopsy-proven nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:53.000081+00:00"}
{"study_id": 101489, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare circulating cytokine levels, including soluble receptor for advanced glycation end-products (sRAGE), in obese versus lean subjects and assess changes after bariatric surgery.", "results_summary": "sRAGE was inversely correlated with weight and BMI in obese subjects, suggesting a potential role in metabolic dysfunction. The study did not report direct effects of advanced glycation end products (AGEs) but highlighted sRAGE's association with obesity-related markers.", "population_specificity": "37 obese patients and 37 lean controls, with an additional 25 obese patients post-bariatric surgery.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:53.996520+00:00"}
{"study_id": 101490, "supplement_id": 857, "safety_score": "70", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to summarize the beneficial effects and underlying mechanisms of puerarin on diabetes mellitus (DM) and its complications, particularly its role in inhibiting advanced glycation end products (AGEs) formation.", "results_summary": "Puerarin may benefit DM by reducing blood glucose, improving insulin resistance, protecting islets, and inhibiting AGEs formation. It also shows potential in mitigating DM complications like cardiovascular issues, nephropathy, retinopathy, and neuropathy, though its efficacy is relatively low due to pharmacokinetic limitations.", "population_specificity": "Not specified (general DM and complications context).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:58.571426+00:00"}
{"study_id": 101492, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review therapeutic approaches targeting AGEs and RAGE for managing diabetes and its complications.", "results_summary": "The abstract highlights that AGEs and RAGE play a significant role in diabetic complications and discusses various therapeutic strategies, including AGE inhibitors, RAGE antagonists, and dietary approaches, though specific clinical outcomes are not detailed.", "population_specificity": "Patients with diabetes mellitus and related complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:10:59.050822+00:00"}
{"study_id": 101493, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) and their receptors in the development and progression of coronary artery disease (CAD) in patients with diabetes mellitus (DM).", "results_summary": "The study suggests that AGEs may contribute to CAD through mechanisms like protein cross-linking, inflammation, oxidative stress, and vascular smooth muscle apoptosis, but clinical evidence remains limited and contradictory. AGEs could serve as biomarkers for CAD severity, but further research is needed to confirm their utility in risk assessment and intervention decisions.", "population_specificity": "Patients with diabetes mellitus (DM) and coronary artery disease (CAD).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:00.532998+00:00"}
{"study_id": 101495, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of RAGE and its ligands, including Advanced Glycation End Products, in lung-associated diseases and explore potential therapeutic interventions.", "results_summary": "The study found that supraphysiological levels of RAGE and its ligands contribute to inflammation and oxidative stress, leading to various lung diseases. Pharmacological agents targeting RAGE production or activity may offer therapeutic benefits.", "population_specificity": "Pulmonary tissues and lung epithelial cells (not human subjects).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:01.291160+00:00"}
{"study_id": 101496, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate serum levels of AGEs and sRAGE as potential biomarkers in idiopathic pulmonary fibrosis (IPF) and their correlation with disease progression.", "results_summary": "The study found that IPF and cHP groups had significantly higher AGE/sRAGE serum concentrations compared to fNSIP patients. Serum sRAGE levels correlated with lung function values, and lower sRAGE levels were associated with poorer survival rates.", "population_specificity": "62 IPF patients, 22 cHP patients, 20 fNSIP patients, and 12 healthy controls, with 23 IPF patients re-evaluated after 3 years.", "effective_dosage": "Not specified", "study_duration": "3-year follow-up for a subset of IPF patients", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:03.751007+00:00"}
{"study_id": 101494, "supplement_id": 857, "safety_score": "40", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the health effects of dietary Advanced Glycation End Products (AGEs), examining both potential benefits and risks, and highlighting gaps in current knowledge.", "results_summary": "The study found that dietary AGEs are partially absorbed and accumulate in tissues, but evidence on their health effects is incomplete and contradictory, with some studies suggesting benefits from restriction while others indicate possible positive outcomes. The abstract also emphasizes the lack of research on single chemically defined AGEs, habitual dietary intake, and effects in vulnerable populations.", "population_specificity": "General human population, with specific mention of vulnerable groups like infants and the elderly.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:03.918286+00:00"}
{"study_id": 101497, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the role of advanced glycation end-products (AGEs) in vascular inflammation, vasoconstriction, thrombosis, and atherogenesis in Type 2 diabetes (T2D) patients with or at risk for cardiovascular disease.", "results_summary": "The study found that hyperglycemia, insulin resistance, and excess fatty acids increase oxidative stress and AGEs, contributing to vascular complications. Intensive T2D treatment, including glucose-lowering therapies, reduced major macrovascular and microvascular events by \u226510%.", "population_specificity": "Adults with Type 2 diabetes (T2D) who have or are at risk for cardiovascular disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:04.113765+00:00"}
{"study_id": 101498, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether methylglyoxal (MG), 3-deoxyglucosone (3-DG), and pentosidine influence outcomes in chronic kidney disease (CKD) patients.", "results_summary": "Higher methylglyoxal (MG) concentrations were closely associated with CKD and may contribute to renal function deterioration. MG concentration could be useful for determining prognosis in CKD patients.", "population_specificity": "150 outpatients with CKD stages 3-5 (mean age 62 \u00b1 12 years, 97 men, 20 with diabetic nephropathy).", "effective_dosage": "Not specified", "study_duration": "3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:05.137465+00:00"}
{"study_id": 101499, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of the glyoxalase system and methylglyoxal (MG) in the pathogenesis of Alzheimer's disease (AD) and explore the potential of inhibiting advanced glycation end products (AGEs) for AD treatment.", "results_summary": "The study found that MG, an active substance of AGEs, contributes to nerve cell damage and is linked to AD onset and progression. Increasing glyoxalase activity and reducing MG levels may inhibit oxidative stress and AGE formation, potentially alleviating AD symptoms.", "population_specificity": "Not specified (focus on mechanisms in AD pathology).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:08.959085+00:00"}
{"study_id": 101502, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of methylglyoxal in diabetic chronic kidney disease (CKD) and evaluate potential therapeutic interventions targeting its accumulation.", "results_summary": "Higher plasma methylglyoxal levels were linked to declining kidney function, and interventions reducing methylglyoxal levels showed reduced albuminuria in diabetic rodent models. The glyoxalase system was identified as a protective mechanism against diabetic CKD.", "population_specificity": "Human and rodent studies (diabetic models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:10.832897+00:00"}
{"study_id": 101500, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of quercetin and epicatechin on plasma concentrations of methylglyoxal (MGO) and advanced glycation end products (AGEs) in humans.", "results_summary": "Quercetin significantly reduced plasma MGO concentrations by 11% compared to baseline, while epicatechin had no effect on MGO or AGE levels. Neither flavonoid significantly altered glyoxal (GO), 3-deoxyglucosone (3-DG), or free and protein-bound AGEs.", "population_specificity": "Apparently healthy, nonsmoking adults with systolic blood pressure between 125 and 160 mm Hg.", "effective_dosage": "Quercetin 3-glucoside (160 mg/d), (-)-epicatechin (100 mg/d).", "study_duration": "4 weeks per intervention, separated by 4-week washout periods.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:10.933951+00:00"}
{"study_id": 101501, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of RAGE signaling in skeletal muscle physiology, including development, regeneration, and pathological conditions, and to highlight potential therapeutic strategies targeting RAGE.", "results_summary": "The study found that RAGE signaling is crucial for skeletal muscle development and regeneration but aberrant re-expression/activity in adult muscle is linked to muscle wasting in aging, genetic disorders, inflammation, cancer, and metabolic alterations. Potential therapeutic strategies targeting RAGE were discussed to improve muscle function.", "population_specificity": "Not specified (review of mechanisms and conditions, not a clinical study)", "effective_dosage": "Not available", "study_duration": "Not applicable (review article)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:11.166378+00:00"}
{"study_id": 101505, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of Aldo-keto reductases (AKR) in compensating for Glyoxalase I (Glo1) deficiency to prevent methylglyoxal (MG) accumulation in diabetic complications.", "results_summary": "The study found that AKR can effectively compensate for GLO1 deficiency to prevent MG accumulation, suggesting a potential protective mechanism against diabetic complications.", "population_specificity": "Not specified (likely diabetic models or in vivo systems).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:12.843975+00:00"}
{"study_id": 101504, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of weight-loss via alternate day fasting (ADF) on soluble RAGE (sRAGE) isoforms and evaluate potential relationships with body composition.", "results_summary": "The study found that ADF led to significant weight loss and changes in sRAGE isoforms, with improvements in body composition related to increased sRAGE isoforms, suggesting sRAGE as a potential target for obesity treatment.", "population_specificity": "42 obese participants", "effective_dosage": "ADF group consumed 25% or 125% of their caloric requirements on alternating days", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:15.005366+00:00"}
{"study_id": 101503, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether biocompatible dual chamber dialysates, which contain fewer advanced glycation end products (AGEs), resulted in lower skin autofluorescence (SAF) compared to standard dialysates in peritoneal dialysis patients.", "results_summary": "The study found that SAF was lower in patients using biocompatible dual chamber dialysates, but this association was not independent on multivariable analysis. SAF was independently associated with factors like comorbidity grade, duration of PD therapy, ethnicity, and serum albumin levels.", "population_specificity": "150 peritoneal dialysis patients (57.3% male, median age 62 years) established on PD for >3 months.", "effective_dosage": "Not specified", "study_duration": "Median duration of PD treatment was 17 months (range 8.6-34.3 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:15.182739+00:00"}
{"study_id": 101506, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the immunomodulatory effects of dietary Maillard reaction products (MRPs) and advanced glycation end products (AGEs) in livestock and pet animals, bridging gaps in understanding their impact on gut inflammation and immune responses.", "results_summary": "The study highlights that MRPs/AGEs in animal feeds can modulate immune responses, potentially contributing to chronic inflammatory states in the gut, though their immunomodulatory effects in animals are less understood compared to humans. The review suggests that improving knowledge in this area could enhance feed quality and prevent diet-mediated inflammation in animals.", "population_specificity": "Livestock and pet animals", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:16.685739+00:00"}
{"study_id": 101508, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cardiovascular benefits of metformin, particularly its effects on reducing advanced glycation end-products (AGEs) and improving heart function in diabetic patients and those with heart failure.", "results_summary": "Metformin was found to reduce AGE deposition, improve myocardial energy metabolism, and preserve cardiac function by activating AMPK, increasing nitric oxide bioavailability, and limiting fibrosis and apoptosis. Preclinical and clinical studies support its cardiovascular safety, but large-scale trials are needed for confirmation.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM) and heart failure (HF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:19.281348+00:00"}
{"study_id": 101509, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of HMG-R inhibitors in reducing AGE-RAGE interactions and glyco-oxidized LDL to mitigate diabetes-associated complications.", "results_summary": "The study suggests that HMG-R inhibitors may decrease LDL uptake, regulate cholesterol synthesis, and reduce oxidative and inflammatory stress, potentially protecting against diabetic complications like nephropathy, neuropathy, and retinopathy.", "population_specificity": "Focused on diabetes-associated complications, particularly diabetic nephropathy, neuropathy, and retinopathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:20.345370+00:00"}
{"study_id": 101511, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) and their receptors (RAGE and TLRs) in recognizing microbial and damage-associated molecular patterns, and their involvement in inflammation and immune responses.", "results_summary": "The study found that RAGE and TLRs recognize PAMPs and DAMPs, triggering inflammation and immune responses, which can lead to tissue damage if excessive but are crucial for protection against infection.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:21.292394+00:00"}
{"study_id": 101510, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of Tocotrienol-rich vitamin E (Tocovid) on diabetic nephropathy in patients with type 2 diabetes, focusing on its impact on Advanced Glycation End Products (AGEs) and related biomarkers.", "results_summary": "The study assessed baseline parameters like AGE, sRAGE, N\u03b5-CML, and Cystatin C for correlation with diabetic nephropathy, but specific results regarding Tocovid's effects on AGEs were not detailed in the abstract.", "population_specificity": "Patients with type 2 diabetes and diabetic nephropathy or urine microalbuminuria (UACR >10 mg/mmol).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:21.708141+00:00"}
{"study_id": 101512, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the etiology, mechanism, and production of Advanced Glycation End Products (AGEs) and their clinical relevance, particularly in relation to breast cancer, focusing on the interplay with glutathione (GSH) and RAGE ligands.", "results_summary": "The study found that AGEs and RAGE ligands, in association with GSH, play a significant role in breast cancer progression, including tumor proliferation, migration, and metastasis. Targeting AGEs and managing GSH expression could have therapeutic implications for breast cancer treatment.", "population_specificity": "Breast cancer patients and related research contexts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:22.889248+00:00"}
{"study_id": 101513, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review potential molecular targets beyond TSPO for PET imaging of neuroinflammation in neurodegenerative diseases.", "results_summary": "The abstract highlights the role of neuroinflammation in neurological diseases and discusses alternative molecular targets for PET imaging, such as enzymes, receptors, and signaling pathways, to improve specificity and quantitation.", "population_specificity": "Not specified (focus on molecular targets for neuroinflammation imaging).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:23.238130+00:00"}
{"study_id": 101514, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the association of Advanced Glycation End Products (AGE) and their receptor (RAGE) with inflammation, oxidative stress, and progression of Inflammatory Bowel Disease (IBD) to Colorectal Cancer (CRC).", "results_summary": "The study found that AGE/RAGE are involved in inflammation progression, with increased RAGE levels and polymorphisms observed in IBD patients. These alterations, combined with oxidative stress, contribute to IBD symptoms and progression to CRC.", "population_specificity": "Patients with Inflammatory Bowel Disease (IBD) and potential progression to Colorectal Cancer (CRC).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:24.978756+00:00"}
{"study_id": 101515, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of advanced glycation end products (AGEs) in the pathophysiology of PCOS, particularly ovarian dysfunction, and the potential of vitamin D to mitigate AGEs' adverse effects.", "results_summary": "The study found that AGEs and their receptors contribute to ovarian dysfunction in PCOS, while vitamin D may attenuate or reverse these effects, suggesting potential for targeted therapies.", "population_specificity": "Women with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:25.709263+00:00"}
{"study_id": 101516, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the therapeutic potential of DNA-aptamers targeting the AGE-RAGE axis for treating diabetes-associated complications, particularly vascular complications and cancer.", "results_summary": "The study highlights that AGEs contribute to diabetes- and aging-related disorders by altering molecular structures and inducing oxidative stress and inflammation via RAGE. It suggests that inhibiting the AGE-RAGE axis with aptamers could be a promising therapeutic strategy.", "population_specificity": "Not specified (focus on mechanistic and therapeutic potential rather than a specific human population).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:28.965614+00:00"}
{"study_id": 101519, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review promising approaches to inhibit RAGE signaling and provide an updated summary of progress in this area.", "results_summary": "The abstract highlights the challenges in targeting RAGE due to its diverse ligands, variants, and signaling pathways, but does not present specific results on the effectiveness of any particular intervention.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:29.923804+00:00"}
{"study_id": 101518, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of hyperglycemia-associated HSP70 in diabetic vasculopathies via the TLR4 pathway and its potential as a therapeutic target.", "results_summary": "The study suggests that HSP70, released under hyperglycemic conditions, binds to TLR4 and triggers pro-inflammatory cytokines via the MyD88-dependent pathway, contributing to diabetic vasculopathies. Preliminary results indicate this pathway may be a new target for therapeutic intervention.", "population_specificity": "Diabetic patients, specifically focusing on vascular system implications.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:30.633667+00:00"}
{"study_id": 101517, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to clarify the associations between cleaved receptor for advanced glycation end-products (cRAGE) levels, disease severity, and functional outcome in aneurysmal subarachnoid hemorrhage (aSAH) patients.", "results_summary": "Plasma cRAGE levels were significantly higher in aSAH patients than controls and correlated with disease severity scores. cRAGE emerged as an independent predictor for poor 6-month outcomes and improved the predictive accuracy of existing severity scores.", "population_specificity": "108 aSAH patients and 108 controls.", "effective_dosage": "Not specified.", "study_duration": "Observational study with 6-month outcome assessment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:31.019075+00:00"}
{"study_id": 101521, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationships among Type 2 diabetes (T2D), diabetic peripheral neuropathy (DPN), and obstructive sleep apnea (OSA), including the role of advanced glycation end products (AGEs) in these conditions.", "results_summary": "The abstract highlights that AGE accumulation is one of several molecular mechanisms implicated in DPN and OSA, but it does not provide specific findings on AGEs' effects. The study reviews shared pathways but does not present new experimental results.", "population_specificity": "Patients with Type 2 diabetes, particularly those with diabetic peripheral neuropathy and obstructive sleep apnea.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:34.434944+00:00"}
{"study_id": 101522, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the correlation between serum sRAGE levels and the clinical severity of acute bronchiolitis in infants, as well as its potential predictive value for recurrent wheezing.", "results_summary": "Serum sRAGE levels were significantly lower in infants with acute bronchiolitis compared to controls but did not correlate with disease severity, viral cause, or recurrent wheezing at 1 year. The study found a negative correlation between sRAGE levels and infant age.", "population_specificity": "Hospitalized infants under 1 year of age with acute bronchiolitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:34.470797+00:00"}
{"study_id": 101523, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of probiotics on metabolic and genetic profiles, including advanced glycation end products (AGEs), in patients with diabetic nephropathy.", "results_summary": "Probiotic supplementation significantly reduced advanced glycation end products (P < 0.001) alongside improvements in glycemic control, lipid profiles, and markers of inflammation and oxidative stress.", "population_specificity": "60 patients with diabetic nephropathy (30 in probiotic group, 30 in placebo group).", "effective_dosage": "8 \u00d7 10^9 CFU/day probiotic supplements.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:35.147785+00:00"}
{"study_id": 101520, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of advanced glycation end products (AGEs) in skin aging and their potential as biomarkers for systemic aging and organ-specific diseases.", "results_summary": "The study found that AGEs, along with dermal collagen content and Wnt signaling pathway alterations, may predict aging status in cardiovascular, brain, and bone systems, suggesting skin biomarkers could indicate systemic aging and disease progression.", "population_specificity": "Not specified (general human aging context).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:37.697159+00:00"}
{"study_id": 101525, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether advanced glycation end-products (AGEs) could serve as promising biomarkers for late diabetic complications.", "results_summary": "The study suggests that AGEs, measured non-invasively in tissues like skin or lens, may be useful biomarkers for diabetic complications, but further research is needed before clinical implementation.", "population_specificity": "Patients with diabetes (specific population not detailed in abstract).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:38.033910+00:00"}
{"study_id": 101524, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of hyperglycaemia and glucose overload, including the accumulation of advanced glycation end-products (AGEs), in the pathophysiology of diabetic cardiomyopathy.", "results_summary": "The study found that hyperglycaemia and glucose overload in cardiomyocytes promote oxidative stress, AGE accumulation, and chronic activation of the hexosamine pathway, leading to apoptosis, altered heart contractility, and mitochondrial dysfunction. Recent clinical trials suggest cardiovascular benefits with SGLT2-inhibitors, indirectly implicating AGEs in diabetic cardiomyopathy.", "population_specificity": "Type 2 diabetes patients at risk for or with heart failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:39.530249+00:00"}
{"study_id": 101527, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether skin autofluorescence (SAF), a measure of Advanced Glycation End Products (AGE) accumulation, correlates with diabetic peripheral neuropathy (DPN) severity.", "results_summary": "The study found that SAF was significantly higher in individuals with DPN and increased with DPN severity, as measured by multiple neuropathy assessment tools (TCNS, NDS, NSS). SAF measurement may help identify high-risk individuals for DPN.", "population_specificity": "497 individuals with diabetes mellitus across 8 centers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:40.334555+00:00"}
{"study_id": 101526, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical usefulness of glycated albumin (GA) as a glycemic index in patients with chronic kidney disease (CKD) and its potential role in diabetic nephropathy pathogenesis.", "results_summary": "The study found that GA is a more reliable and sensitive glycemic marker than HbA1c in CKD patients, reflecting postprandial glucose and glycemic excursions more rapidly. High GA levels may correlate with adverse outcomes in CKD patients, suggesting its role in advanced glycation end products (AGEs)-related cellular alterations.", "population_specificity": "Patients with diabetes and chronic kidney disease (CKD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:40.722955+00:00"}
{"study_id": 101529, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to discuss the neuroprotective effects of erythropoietin (EPO) on pathogenic mechanisms of diabetic neuropathy, including the role of advanced glycation end-products (AGEs).", "results_summary": "The study suggests that EPO may reverse diabetic neuropathy by reducing oxidative stress, decreasing pro-inflammatory cytokines, restoring Na+/K+-ATPase activity, and blocking pro-apoptotic proteins, which are linked to AGEs accumulation.", "population_specificity": "Diabetic patients with neuropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:43.437133+00:00"}
{"study_id": 101528, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to elucidate the role of Advanced Glycation End Products (AGEs) in the pathogenesis of diabetic retinopathy (DR) and explore potential therapeutic interventions targeting AGEs.", "results_summary": "The study found that AGEs contribute to diabetic retinopathy by inducing vascular dysfunction, inflammation, and breakdown of the blood-retinal barrier, and highlighted ongoing research into anti-AGE therapies.", "population_specificity": "Individuals with diabetes, particularly those at risk for or suffering from diabetic retinopathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:43.804743+00:00"}
{"study_id": 101530, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the role of Advanced Glycation End Products (AGEs) in Parkinson's disease (PD) pathology and explore potential biotherapeutic countermeasures.", "results_summary": "The study found that AGEs and their receptors (RAGEs) contribute to a prooxidant environment in PD, promoting Alpha synuclein aggregation. It also highlighted a potential therapeutic strategy using recombinant atoxic derivatives of botulinum neurotoxins to target cytoprotective enzymes in affected neurons.", "population_specificity": "General discussion of PD pathology, no specific population studied.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:44.678767+00:00"}
{"study_id": 101532, "supplement_id": 857, "safety_score": "50", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to review the current scientific knowledge on Advanced Glycation End Products (AGEs), focusing on their occurrence in foods, daily uptake, contribution to endogenous levels, and effects on health-related biomarkers in humans.", "results_summary": "The abstract highlights conflicting evidence on the health risks of dietary AGEs, with some studies linking them to clinical outcomes while others found no association, prompting a call for interdisciplinary approaches to resolve the debate.", "population_specificity": "Not specified (general human health focus).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:47.014284+00:00"}
{"study_id": 101531, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the role of advanced glycation end products (AGEs) in cartilage aging and oxidative stress within the osteoarthritis (OA) process, focusing on their impact on extracellular matrix properties and chondrocyte apoptosis.", "results_summary": "The study found that AGEs contribute to cartilage degradation by altering extracellular matrix properties and promoting chondrocyte apoptosis, with NADPH oxidase (particularly Nox4) playing a key role in ROS-mediated signaling and ECM degradation via MMP-1 and MMP-13 proteins.", "population_specificity": "Osteoarthritis patients (implied by focus on cartilage degradation and chondrocytes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:48.044251+00:00"}
{"study_id": 101536, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the role of the AGE-RAGE axis in diabetic nephropathy and evaluate potential therapeutic strategies targeting this pathway.", "results_summary": "The study highlights that AGE-RAGE axis activation contributes to diabetic nephropathy by inducing oxidative stress and inflammation, and experimental models show promise with AGE-lowering and RAGE-inhibiting compounds, though clinical trials are lacking.", "population_specificity": "Diabetic nephropathy patients (type 1 and type 2 diabetes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:49.407364+00:00"}
{"study_id": 101533, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of HMGB-1 and its interaction with RAGE (receptor for advanced glycation end products) in thrombosis-related diseases and potential therapeutic strategies targeting HMGB-1.", "results_summary": "The study found increased expression of HMGB-1 in thrombosis-related diseases and summarized its link to thrombosis through platelets, NETs, and coagulation factors, suggesting HMGB-1 as a potential therapeutic target.", "population_specificity": "Patients with thrombosis-related diseases (coronary artery disease, stroke, peripheral arterial disease, disseminated intravascular coagulation, venous thrombosis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:49.570135+00:00"}
{"study_id": 101535, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of hemodiafiltration (HDF) versus high-flux hemodialysis (HD) on biomarkers of inflammation, oxidative stress, and endothelial dysfunction, including Advanced Glycation End Products (AGEs), in children.", "results_summary": "The study found a significant reduction in AGEs (p<0.01) and other biomarkers of oxidative stress and inflammation after switching from HD to HDF, suggesting improved clearance and reduced endothelial risk. Higher convective volumes during HDF were associated with lower ox-LDL levels.", "population_specificity": "22 children (13 female, aged 8-15 years) with at least 3 months of prior HD treatment.", "effective_dosage": "Not specified", "study_duration": "3 months of HDF therapy", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:51.219786+00:00"}
{"study_id": 101537, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review biological pathways, including Advanced Glycation End Products, that may explain the negative association between diabetes and abdominal aortic aneurysm.", "results_summary": "The study identified that Advanced Glycation End Products, among other pathways, may limit the presence, growth, and rupture of abdominal aortic aneurysms. It also suggested that diabetes medications could influence aneurysm development.", "population_specificity": "Not specified (literature review)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:51.778424+00:00"}
{"study_id": 101539, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to identify clinical and biological parameters associated with plasma levels of soluble RAGE in ICU patients.", "results_summary": "The study found no significant association between ICU admission parameters and baseline plasma levels of soluble RAGE or esRAGE. Multidimensional analyses did not reveal any clear links.", "population_specificity": "Adult ICU patients with at least one ARDS risk factor.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:52.640839+00:00"}
{"study_id": 101538, "supplement_id": 857, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to review the mechanistic effects of benfotiamine (BFT) on reducing advanced glycation end products (AGEs) and its pleiotropic effects on other molecular pathways in diabetic vascular complications.", "results_summary": "BFT activates transketolase, redirecting AGE precursors to the pentose phosphate pathway, thereby reducing AGE production and subsequent metabolic stress. It also modulates non-AGE pathways like NF-\u03ba\u03b2, MAPK, and VEGFR2, demonstrating broad therapeutic potential.", "population_specificity": "Diabetic individuals with vascular complications (implied by context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:54.614185+00:00"}
{"study_id": 101540, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the association between HDL oxidation (HDLox) and glycation, as measured by sRAGE and esRAGE levels, in people with HIV-1 and uninfected individuals to understand their role in HIV-related cardiovascular disease.", "results_summary": "Higher baseline sRAGE levels in people with HIV on effective anti-retroviral therapy were associated with higher HDLox, while esRAGE showed inverse relationships with HDLox changes. Glycation and oxidation of HDL may impair its function in people with HIV.", "population_specificity": "People with HIV-1 (PWH) on effective anti-retroviral therapy and uninfected individuals.", "effective_dosage": "Not specified", "study_duration": "3-year study with assessments over 96 of 144 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:58.357702+00:00"}
{"study_id": 101543, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to update current data on AGEs sources and metabolism, their impact on oral cavity tissues, and suggest new approaches for early diagnosis and treatment of AGEs-related oral pathology.", "results_summary": "The study found that AGEs induce chronic inflammation and are associated with dental and periodontal pathology. Salivary AGEs levels correlate with general and oral pathology, suggesting their potential as a diagnostic tool.", "population_specificity": "Human and animal model studies (no specific population detailed).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:58.595739+00:00"}
{"study_id": 101541, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of chelation therapy (EDTA) in reducing cardiovascular disease (CVD) events, particularly focusing on its potential role in mitigating advanced glycation end products (AGEs)-related atherosclerosis in diabetic patients.", "results_summary": "The study found that chelation therapy improved outcomes in post-myocardial infarction patients, with a notable reduction in CVD events and all-cause mortality in diabetic patients, suggesting a possible mechanism involving reduced metal-catalyzed oxidation and AGE formation.", "population_specificity": "Post-myocardial infarction patients, with a prespecified subgroup of diabetic patients.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:11:58.596978+00:00"}
{"study_id": 101544, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether switching from DPP-4 inhibitors to tofogliflozin improves arterial stiffness in T2DM patients and whether baseline serum levels of AGEs predict treatment response.", "results_summary": "Switching to tofogliflozin significantly reduced AGEs and improved arterial stiffness, with higher baseline AGEs associated with better response. Liver function improvements were also linked to reduced arterial stiffness.", "population_specificity": "Nineteen Type 2 Diabetes Mellitus (T2DM) patients previously on DPP-4 inhibitors for at least 1 year.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:00.781740+00:00"}
{"study_id": 101542, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of p38 MAPK inhibitors, including natural compounds, in mitigating Alzheimer's disease pathology by targeting mechanisms like A\u03b2 toxicity and neuroinflammation.", "results_summary": "The study found that p38 MAPK inhibitors, such as SB202190, SB203580, MW108, and PD169316, as well as natural compounds from green tea, olive oil, propolis, and puerarine extract, showed promising anti-apoptotic, anti-inflammatory, and cognitive-enhancing effects in animal models, though clinical efficacy may be limited due to side effects or cross-reactivity.", "population_specificity": "Animal models (in vivo and in vitro studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:00.905545+00:00"}
{"study_id": 101546, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to examine the effects of diabetes and diabetes therapy on bone health, including the impact of various antidiabetic agents.", "results_summary": "The study found that most antidiabetic agents have neutral or positive effects on bone, but some, like insulin and thiazolidinediones, may increase fracture risk. Metabolic surgery also negatively impacts bone strength.", "population_specificity": "Patients with diabetes (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:01.821604+00:00"}
{"study_id": 101545, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine the relationship between skin autofluorescence (SAF) as a measure of advanced glycation end products (AGEs) and plaque composition in patients with cardiovascular disease (CVD).", "results_summary": "The high SAF group showed significantly more thin cap fibroatheroma (TCFA), calcified plaques, and ruptured plaques compared to the low SAF group. SAF, along with LDL and other factors, was independently associated with plaque vulnerability, suggesting its clinical utility in identifying high-risk CVD patients.", "population_specificity": "108 patients with cardiovascular disease undergoing percutaneous coronary intervention (PCI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:01.935008+00:00"}
{"study_id": 101547, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to discuss the characteristics and mechanisms of diabetes mellitus (DM) and heart failure with preserved ejection fraction (HFpEF), focusing on the role of advanced glycation end products (AGEs) in disease pathogenesis.", "results_summary": "The study highlights that AGE deposition contributes to the structural and functional abnormalities in HFpEF hearts, including endothelial dysfunction, fibrosis, and cardiomyocyte stiffness, but current therapeutic strategies have limited impact on improving outcomes.", "population_specificity": "Patients with diabetes mellitus (DM) and heart failure with preserved ejection fraction (HFpEF).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:04.389132+00:00"}
{"study_id": 101548, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the pathophysiological links between diabetes and hypertension, including the role of advanced glycation end products in diabetic kidney disease.", "results_summary": "The abstract mentions that advanced glycation end products contribute to the pathophysiology of diabetic kidney disease, but no specific efficacy or safety results are provided.", "population_specificity": "People with diabetes and hypertension.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:06.061237+00:00"}
{"study_id": 101549, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to survey molecular mechanisms linking oxidative stress, including the role of advanced glycation end products, to neurodegenerative diseases.", "results_summary": "The study found that oxidative stress, including the formation of advanced glycation end products, contributes to neurodegenerative diseases through mechanisms like mitochondrial dysfunction, inflammation, and protein oxidation. Modulating oxidative stress was suggested as a potential therapeutic strategy.", "population_specificity": "Not specified (general review of neurodegenerative disease mechanisms).", "effective_dosage": "Not available", "study_duration": "Not applicable (literature review)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:07.641411+00:00"}
{"study_id": 101552, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the pathophysiological role of RAGE ligands, including Advanced Glycation End Products (AGEs), in peripheral artery disease (PAD) and assess their potential as biomarkers and therapeutic targets.", "results_summary": "The study found that AGEs contribute to vascular stiffness and atherosclerotic plaque instability in diabetic patients, and their interaction with RAGE promotes inflammatory and thrombotic reactions, worsening PAD severity and prognosis.", "population_specificity": "Diabetic patients with symptomatic peripheral artery disease (PAD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:10.629598+00:00"}
{"study_id": 101550, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the presence and clinical relevance of amyloid-like protein aggregates, including advanced glycation end products, in serum and urine of women with preeclampsia compared to controls.", "results_summary": "The study found increased serum and urine ThT fluorescence (indicative of advanced glycation end products) in women with severe preeclampsia compared to healthy pregnant controls, suggesting a link between these aggregates and disease severity. No gestational age-related changes in ThT fluorescence were observed, though near-term serum ThT fluorescence increased compared to the nonpregnant state.", "population_specificity": "Pregnant women with severe preeclampsia (n=101), mild preeclampsia (n=22), chronic hypertension (n=15), healthy pregnant controls (n=57), and nonpregnant controls (n=22).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:10.812417+00:00"}
{"study_id": 101551, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether a ternary-complex (RBP/PEI2k/pHSVtk) could effectively inhibit RAGE-mediated tumor angiogenesis and deliver a suicide gene for glioblastoma treatment.", "results_summary": "The ternary-complex demonstrated higher transfection efficiency, reduced VEGF secretion, inhibited tube formation in endothelial cells, and showed superior anti-tumor and anti-angiogenic effects compared to binary complexes in both in vitro and in vivo glioblastoma models.", "population_specificity": "Intracranial glioblastoma animal model (not human subjects).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:11.006168+00:00"}
{"study_id": 101554, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in diabetic polyneuropathy (DPN), focusing on their impact on sensory neuron degeneration and potential therapeutic interventions.", "results_summary": "The study found that diabetic sensory neurons exhibit increased receptor for AGEs, alongside other molecular changes, contributing to neurodegeneration. Interventions like insulin signaling activation and microRNA replenishment showed potential in reversing neuropathic abnormalities in experimental DPN models.", "population_specificity": "Diabetic sensory neurons (experimental models of diabetic polyneuropathy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:12.205319+00:00"}
{"study_id": 101553, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of inflammation, including the involvement of advanced glycation end-products, in the pathophysiology of diabetic retinopathy, with a focus on neuro-glial relationships.", "results_summary": "The abstract highlights that advanced glycation end-products contribute to the inflammatory response in diabetic retinopathy, but it does not provide specific findings on their direct effects or outcomes. The review summarizes recent advances in targeting inflammation but does not detail results related to advanced glycation end-products.", "population_specificity": "Diabetic retinopathy patients (working-age population with diabetes)", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:12.910128+00:00"}
{"study_id": 101555, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of Advanced Glycation End Products in the pathogenesis of arterial stiffness in end-stage renal disease (ESRD) and discuss potential therapeutic interventions.", "results_summary": "The abstract suggests that Advanced Glycation End Products may contribute to arteriosclerosis in ESRD, but it does not provide specific efficacy or safety data regarding their effects. The focus is on broader mechanisms and therapeutic strategies, including blood pressure control.", "population_specificity": "Patients with end-stage renal disease (ESRD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:14.962004+00:00"}
{"study_id": 101557, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to elucidate the role of RAGE in Parkinson's disease (PD) pathogenesis and highlight anti-RAGE strategies for PD treatment.", "results_summary": "The study found that RAGE is highly expressed in PD patients and is involved in neuroinflammation, apoptosis, and oxidative stress, contributing to neuron death. RAGE ablation protected dopaminergic neurons in mice, suggesting potential therapeutic benefits of targeting RAGE in PD.", "population_specificity": "PD patients and MPTP-treated mice (animal model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:17.004890+00:00"}
{"study_id": 101556, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of soluble receptor for advanced glycation end products (sRAGE) and other biomarkers in detecting delayed graft function (DGF) following kidney transplantation.", "results_summary": "The study found that plasmatic total K18 and urinary TIMP-2 and IGFBP7 improved diagnostic performance for DGF, particularly in deceased donor transplants with prolonged cold ischaemia time. sRAGE was measured but its specific efficacy in DGF detection was not highlighted as prominently as the other biomarkers.", "population_specificity": "91 kidney transplant patients (48 deceased donors, 43 living donors).", "effective_dosage": "Not specified", "study_duration": "Samples collected before, immediately after, and up to 10 days post-operation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:17.146714+00:00"}
{"study_id": 101558, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to describe the formation and quantitative importance of Advanced Glycation End Products (AGEs), specifically methylglyoxal (MG)-derived hydroimidazolone MG-H1.", "results_summary": "The abstract mentions that AGEs are stable posttranslational modifications of proteins formed by spontaneous reactions with glucose and related metabolites, with MG-H1 being quantitatively important. No specific study results on effects are provided.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:19.206194+00:00"}
{"study_id": 101560, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the role of Advanced Glycation End Products (AGEs) in the development and progression of diabetic cardiomyopathy.", "results_summary": "The abstract highlights that elevations in AGEs contribute to myocardial fibrosis, dysfunctional remodeling, and stiffness in diabetic cardiomyopathy, alongside other pathophysiological mechanisms. The study does not provide specific results on AGEs' direct effects but implicates them in disease progression.", "population_specificity": "Patients with diabetes mellitus, particularly those developing diabetic cardiomyopathy.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:19.962687+00:00"}
{"study_id": 101559, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the shared vascular mechanisms linking diabetes and hypertension.", "results_summary": "The abstract highlights AGEs as one of the key vascular mechanisms predisposing to both diabetes and hypertension, alongside oxidative stress, inflammation, immune system activation, and microRNAs. It also discusses current and potential therapies targeting these pathways.", "population_specificity": "Patients with hypertension and type 2 diabetes, or those at risk for these conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:21.168723+00:00"}
{"study_id": 101561, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review medicinal plants and their bioactive constituents for their potential to regulate cellular processes involved in diabetic nephropathy (DN) initiation.", "results_summary": "Medicinal plants and their bioactive constituents may slow or ameliorate DN progression by targeting multiple pathological pathways, but efficacy in animal models and humans remains unexplored.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:21.316408+00:00"}
{"study_id": 101562, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the benefits of fasting in osteoarthritis (OA) could be explained by changes in advanced glycation end products (AGEs) or their receptors (RAGE).", "results_summary": "Fasting led to a significant but temporary reduction in sRAGE levels and the sRAGE/CML ratio, while CML levels remained unchanged. Clinical improvements in pain and joint function were observed, but these did not correlate with changes in AGEs or RAGE.", "population_specificity": "37 patients with osteoarthritis", "effective_dosage": "Not specified (therapeutic fasting for 8 days)", "study_duration": "8 days of fasting, with follow-up at 4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:23.313099+00:00"}
{"study_id": 101563, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess whether plasma sRAGE and esRAGE levels, along with AGER SNPs, could predict ARDS development in high-risk ICU patients.", "results_summary": "Higher baseline and day one plasma sRAGE levels were independently associated with increased ARDS risk, while esRAGE showed no such association. The AGER SNP rs2070600 (Ser/Ser) was linked to higher ARDS risk and elevated sRAGE levels.", "population_specificity": "Adult ICU patients with at least one ARDS risk factor upon admission.", "effective_dosage": "Not specified", "study_duration": "Measurements taken at ICU admission and 24 hours later.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:24.918354+00:00"}
{"study_id": 101565, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of vitamin D receptor (VDR) activation by paricalcitol on advanced glycation end products (AGE) and their decoy receptor (RAGE) in CKD patients.", "results_summary": "The study found that VDR activation by paricalcitol influenced S100A12/ENRAGE, RAGE, and myeloperoxidase levels, but not pentosidine, in CKD patients. Baseline correlations were observed between S100A12/ENRAGE, RAGE, and myeloperoxidase.", "population_specificity": "Chronic kidney disease (CKD) patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:27.286181+00:00"}
{"study_id": 101564, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to understand the mechanisms by which Advanced Glycation End Products (AGEs) impair coronary collateral vessel growth in type 2 diabetic patients with chronic total occlusion (CTO).", "results_summary": "The study found that AGEs interact with their receptor, activating harmful intracellular pathways, increasing oxidative stress, and worsening inflammation, which collectively impair collateral vessel growth. Elevated serum levels of glycated albumin and other markers were linked to poor coronary collateralization in diabetic patients.", "population_specificity": "Type 2 diabetic patients with stable coronary artery disease and chronic total occlusion (CTO).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:27.368721+00:00"}
{"study_id": 101566, "supplement_id": 857, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to classify the toxicity of uremic retention solutes, including Advanced Glycation End Products (AGEs), based on their impact on biological systems and clinical evidence.", "results_summary": "AGEs were among the highest-scoring protein-bound compounds for toxicity, affecting multiple biological systems, particularly inflammatory, cardiovascular, and fibrogenic pathways. The study noted robust experimental data but lacked clinical evidence for nearly half of the protein-bound molecules, including AGEs.", "population_specificity": "Patients with chronic kidney disease (CKD) and uremic syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:29.039745+00:00"}
{"study_id": 101569, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) in contributing to reduced bone strength and increased fracture risk in individuals with Type 2 diabetes.", "results_summary": "The study found that AGE accumulation in bone may contribute to reduced bone strength, alongside other factors like reduced bone turnover and structural deficits. However, the exact mechanisms and clinical impact of AGEs remain incompletely understood.", "population_specificity": "Individuals with Type 2 diabetes (T2DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:31.520701+00:00"}
{"study_id": 101570, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to summarize methods for characterizing site-specific glycation in proteins and explore novel areas in Maillard research, including diagnostics and anti-glycative defense.", "results_summary": "The study highlights the heterogeneity and pathogenic role of AGEs in diseases like diabetes and Alzheimer's, emphasizing proteomics as a key tool for understanding glycation mechanisms and developing therapeutic approaches.", "population_specificity": "Not specified (focus on methodological and conceptual review)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:32.043440+00:00"}
{"study_id": 101567, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to review the mechanisms by which perindopril and indapamide target pathways involved in microvascular and macrovascular diabetic complications, including the reduction of advanced glycation end products (AGEs) in diabetic tissue.", "results_summary": "Perindopril/indapamide treatment reduced blood pressure and improved arterial distensibility, kidney function, and endothelial function. It also potentially reduced AGE accumulation in diabetic tissue and significantly lowered the risk of microvascular/macrovascular events, cardiovascular mortality, and all-cause mortality, with long-lasting benefits observed years after treatment.", "population_specificity": "Patients with type 2 diabetes mellitus and hypertension.", "effective_dosage": "Not specified", "study_duration": "Follow-up data included 6 years post-double-blind period (exact intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:32.400739+00:00"}
{"study_id": 101568, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the distinct effects of diabetes mellitus (DM) on myocardial remodeling in heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF), particularly focusing on the role of advanced glycation end products (AGEs) in cardiomyocyte cell death in HFrEF.", "results_summary": "The study found that in HFrEF, DM exacerbates replacement fibrosis due to cardiomyocyte cell death induced by lipotoxicity or advanced glycation end products (AGEs). In contrast, in HFpEF, DM primarily increases cardiomyocyte hypertrophy and stiffness, likely due to hyperinsulinemia and microvascular endothelial inflammation.", "population_specificity": "Patients with diabetic cardiomyopathy and heart failure (HFpEF and HFrEF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:33.557780+00:00"}
{"study_id": 101571, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of RAGE in chronic inflammatory diseases and the potential therapeutic effects of blocking RAGE signaling.", "results_summary": "The study found that RAGE is upregulated in chronic inflammation and mediates cellular responses to DAMPs and PAMPs. Blocking RAGE signaling in models reduced inflammation and progression of diabetic vascular complications, CVD, and cancer.", "population_specificity": "Cell and animal models (specific human population not mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:33.572747+00:00"}
{"study_id": 101572, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of RAGE (receptor for advanced glycation end products) in melanoma progression and its potential as a therapeutic target.", "results_summary": "The study found that RAGE modulates inflammatory, proliferative, and invasive cellular responses in melanoma, with specific ligands like S100 proteins and HMGB1 implicated in metastasis. Targeting RAGE signaling was identified as a viable but underexplored therapeutic strategy for melanoma.", "population_specificity": "In vitro and in vivo melanoma models (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:36.612323+00:00"}
{"study_id": 101573, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of glycoxidative products, particularly advanced glycation end products (AGEs), in lung cancer progression and their potential as therapeutic targets.", "results_summary": "The study suggests that AGE-RAGE binding critically regulates lung cancer progression by modulating signaling pathways like p38 MAPK, NF-\u0199B, and TNF-\u03b1, influencing cell growth, proliferation, and metastasis. It highlights the potential role of oxidation, glycation, and glycoxidation in lung cancer but does not provide definitive therapeutic outcomes.", "population_specificity": "Not specified (review of existing research on lung cancer pathways).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:38.137772+00:00"}
{"study_id": 101574, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of HMGB1 and its interaction with receptors like RAGE (receptor for advanced glycation end products) in ischemic stroke, focusing on neurovascular repair and immunomodulation.", "results_summary": "The study found that HMGB1 activates inflammatory responses via RAGE and other receptors during ischemic stroke but also has beneficial effects like promoting neurite outgrowth and neuronal survival, suggesting its potential as a therapeutic target for post-stroke recovery.", "population_specificity": "Not specified (general focus on ischemic stroke mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:38.703426+00:00"}
{"study_id": 101576, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers reviewed recent evidence on the role of Advanced Glycation End Products (AGEs) in diabetic foot syndrome and increased mortality rates.", "results_summary": "The study found that AGE accumulation is implicated in diabetic vascular disease and neuropathy, contributing to complications like diabetic foot ulcers and higher mortality rates. Elevated triglycerides, oxidative stress, and inflammatory markers were also associated with these outcomes.", "population_specificity": "Diabetic patients, particularly those with diabetic foot syndrome and metabolic syndrome.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:40.944148+00:00"}
{"study_id": 101575, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the potential role of plant extracts in treating diabetes mellitus wounds, focusing on mechanisms involving Advanced Glycation End Products and related cellular processes.", "results_summary": "The review highlights the antihyperglycemic properties of various plant extracts and discusses their potential mechanisms in wound healing, including effects on inflammation, macrophages, non-leukocytic cells, matrix metalloproteinase, and miRNA. It suggests plant extracts could offer effective future treatment options for DM wounds.", "population_specificity": "Not specified (literature review of published studies).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:41.863751+00:00"}
{"study_id": 101577, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify the biochemical pathways, including the role of Advanced Glycation End Products (AGEs), involved in the development of diabetic macroangiopathy.", "results_summary": "The study found that AGEs, along with oxidative stress and other pathways, play a crucial role in diabetic macroangiopathy by contributing to endothelial and vascular smooth muscle cell dysfunction.", "population_specificity": "Patients with diabetes mellitus (DM) at risk for macroangiopathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:42.249111+00:00"}
{"study_id": 101578, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) in diabetes-induced bone fragility and explore potential therapeutic targets like AMPK in osteoblasts and osteocytes.", "results_summary": "The study found that AGEs impair osteoblast and osteocyte function, leading to decreased bone formation and remodeling in diabetic patients. It also suggested that AMPK activation may protect against oxidative stress-induced osteocyte apoptosis and improve bone metabolism.", "population_specificity": "Patients with diabetes mellitus (DM) and potential implications for osteoporosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:43.443151+00:00"}
{"study_id": 101579, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the effects of dietary Advanced Glycation End Products (AGEs) on gut microbiota composition in peritoneal dialysis patients and their potential role in cardiovascular disease.", "results_summary": "Dietary AGE restriction significantly reduced serum N\u03b5-(carboxymethyl) lysine (CML) and methylglyoxal-derivatives (MG) and altered gut microbiota composition, including reduced Prevotella copri and Bifidobacterium animalis and increased Alistipes indistinctus, Clostridium citroniae, Clostridium hathewayi, and Ruminococcus gauvreauii. These changes suggest a potential link between AGEs, gut microbiota, and cardiovascular risk in this population.", "population_specificity": "End-stage renal disease (ESRD) patients undergoing peritoneal dialysis (PD).", "effective_dosage": "Not specified", "study_duration": "One month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:45.040293+00:00"}
{"study_id": 101580, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of CD36 in renal pathophysiology, particularly its involvement in kidney fibrosis and potential as a therapeutic target for chronic kidney disease (CKD).", "results_summary": "The study found that CD36 is upregulated in CKD and contributes to kidney fibrosis by disrupting lipid metabolism. Blocking or genetically knocking out CD36 prevented kidney injury in experimental models, suggesting its potential as a therapeutic target.", "population_specificity": "Experimental models (not specified if human or animal, but likely animal given the mention of genetic knockout).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:46.116404+00:00"}
{"study_id": 101581, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the role of Advanced Glycation End Products (AGEs) as biomarkers and their association with diabetic retinopathy, along with current treatment strategies.", "results_summary": "The abstract highlights that AGEs are among the altered biomarkers linked to diabetic retinopathy, contributing to oxidative stress and inflammation. Current treatments targeting these biomarkers, such as anti-VEGF therapy and intravitreal corticosteroids, are discussed, but specific efficacy data on AGEs are not detailed.", "population_specificity": "Patients with diabetic retinopathy (later stages of diabetes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:47.289045+00:00"}
{"study_id": 101582, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to analyze the relationship between AGEs (measured by skin autofluorescence) and cardiovascular disease (CVD) and bone mineral disorder (BMD) parameters in hemodialysis (HD) patients.", "results_summary": "AGEs-sAF levels were elevated in both HD and control groups, with higher levels in HD patients. AGEs-sAF levels were negatively associated with serum iPTH but showed no relation to ventricular mass, interventricular septum, or vascular calcification in HD patients.", "population_specificity": "Prevalent hemodialysis patients (n=20) and healthy controls (n=24).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:48.564031+00:00"}
{"study_id": 101583, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential benefits and safety of metformin in diabetic patients with heart failure, focusing on its effects on advanced glycation end products (AGEs) and myocardial function.", "results_summary": "Metformin was found to inhibit AGE generation and accumulation, potentially preventing adverse structural and functional changes in the myocardium. It also improved metabolism and mitochondrial function through AMPK activation, though further research is needed to confirm these benefits.", "population_specificity": "Diabetic patients with concomitant heart failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:50.018614+00:00"}
{"study_id": 101584, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in promoting HDL dysfunction and increased cardiovascular disease risks in diabetic patients.", "results_summary": "The study found that hyperglycemia-induced AGEs, oxidative stress, and inflammation contribute to HDL dysfunction, impairing reverse cholesterol transport and increasing CVD risks in diabetes. Therapeutic control of diabetes may mitigate these risks.", "population_specificity": "Diabetic patients with cardiovascular disease risks.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:50.398330+00:00"}
{"study_id": 101585, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the value of biomarkers, including sRAGE, in predicting risk, diagnosis, treatment response, and prognosis of ARDS after trauma.", "results_summary": "The study identified sRAGE as a biomarker with confirmed value in ARDS, linked to key pathogenic processes, but did not specify its direct effects or outcomes.", "population_specificity": "Trauma patients at risk for or diagnosed with ARDS.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:50.630001+00:00"}
{"study_id": 101586, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in bone fragility and fracture risk in patients with diabetes mellitus.", "results_summary": "The study found that AGEs accumulate in bone collagen and contribute to bone quality deterioration, increasing fracture risk in diabetic patients, particularly in type 2 diabetes. Current diagnostic tools like bone mineral density and FRAX are insufficient for assessing fracture risk in these patients, suggesting the need for improved methods.", "population_specificity": "Patients with type 1 and type 2 diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:52.795651+00:00"}
{"study_id": 101589, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the formation, consequences, and clinical relevance of glycated albumin (GA) as a biomarker for diabetes and its complications.", "results_summary": "Elevated GA levels are linked to insulin resistance and diabetic complications. Mass spectrometry-based approaches enable precise characterization and quantification of GA, aiding in disease prediction.", "population_specificity": "Healthy and diabetic individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:55.009078+00:00"}
{"study_id": 101588, "supplement_id": 857, "safety_score": "40", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the role of dietary advanced glycation end products (AGEs) as a cardiometabolic risk factor and evaluate whether evidence supports dietary recommendations to lower AGE intake.", "results_summary": "High intake of dietary AGEs increased inflammation markers and oxidative stress in diabetic subjects, while AGE restriction reduced inflammatory molecules and improved insulin sensitivity in at-risk populations. However, effects in healthy subjects were unclear, and not all studies showed reduced circulating AGEs.", "population_specificity": "Subjects with diabetes mellitus, overweight, obesity, or prediabetes; limited data on healthy subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:55.823276+00:00"}
{"study_id": 101587, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) and their receptors (RAGE and s-RAGE) in cancer initiation and progression, as well as their potential as therapeutic targets.", "results_summary": "The study found that AGEs and their receptor interactions (AGE-RAGE or AGE-sRAGE axis) contribute to carcinogenesis by activating transcription factors and cytokines, potentially serving as biomarkers for cancer. It also highlighted the possible dual role of HMGB1 and S100 proteins in cancer and suggested novel therapeutic targets.", "population_specificity": "Not specified (general discussion on glycation biology and cancer mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:55.825084+00:00"}
{"study_id": 101590, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify metabolic pathway networks, including advanced glycation end products, impacted by rice bran consumption for colorectal cancer chemoprevention.", "results_summary": "Rice bran consumption significantly altered stool metabolites, including changes in advanced glycation end products, steroids, and bile acids, suggesting a favorable modulation of the gut metabolome for CRC prevention.", "population_specificity": "19 colorectal cancer survivors", "effective_dosage": "30 g/day of heat-stabilized rice bran", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:57.027059+00:00"}
{"study_id": 101592, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of high sucrose intake on mechanotransduction proteins and vascular function in humans, including potential changes in advanced glycation end-products (AGE) levels.", "results_summary": "The study found that high sucrose intake impaired vascular function and altered mechanotransduction protein expression, but no measurable changes in AGE levels were observed.", "population_specificity": "12 young healthy male subjects", "effective_dosage": "3 \u00d7 75 g sucrose per day", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:58.530483+00:00"}
{"study_id": 101593, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the levels of DAMPs, including the receptor for advanced glycation end products, between OA knee and hip joints to understand their role in OA pathogenesis.", "results_summary": "The study found significantly higher levels of DAMPs in the knee joint compared to the hip joint, suggesting a difference in OA pathogenesis between these joints and highlighting DAMPs as potential therapeutic targets.", "population_specificity": "Patients with osteoarthritis in knee and hip joints.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:12:59.072139+00:00"}
{"study_id": 101591, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze soluble RAGE (sRAGE) levels in the cerebrospinal fluid (CSF) of subarachnoid hemorrhage (SAH) patients to understand its role as an endogenous anti-inflammatory mechanism.", "results_summary": "The study found significantly higher sRAGE levels in the CSF of SAH patients compared to controls, particularly in samples collected within 0-3 days post-SAH, suggesting a potential anti-inflammatory response.", "population_specificity": "27 SAH patients with acute hydrocephalus.", "effective_dosage": "Not specified", "study_duration": "Samples collected on post-SAH days 0-3, 5-7, and 10-14.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:00.143804+00:00"}
{"study_id": 101594, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to highlight the role of AGE-RAGE interaction in hypoxic cancer cells and explore its potential as a therapeutic target.", "results_summary": "The study found that elevated glucose levels induce glycation, leading to AGE accumulation, which binds to RAGE and triggers aberrant signaling pathways linked to diseases like cancer. Inhibition of AGE-RAGE interaction may be a potential therapeutic strategy for cancer progression.", "population_specificity": "Hypoxic cancer cells (in vitro or theoretical context, not specified).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:01.364766+00:00"}
{"study_id": 101595, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review current advances in the therapy of diabetic neuropathy, including the role of benfotiamine in inhibiting pathways leading to Advanced Glycation End Products (AGEs).", "results_summary": "Benfotiamine was found to inhibit pathways triggered by uncontrolled glucose influx, including the formation of AGEs, suggesting potential efficacy in managing diabetic neuropathy. Alpha-lipoic acid also demonstrated efficacy in ameliorating neuropathic symptoms.", "population_specificity": "Patients with diabetic neuropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:03.642889+00:00"}
{"study_id": 101596, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review inflammatory mediator expression, including the receptor for advanced glycation end products (RAGE), in the context of clinical diagnosis of reversible and irreversible pulpitis.", "results_summary": "The study found that RAGE expression increases during inflammation, and its levels, along with other inflammatory mediators, may help distinguish between reversible and irreversible pulpitis. The difference in expression between these conditions is both quantitative and qualitative.", "population_specificity": "Dental pulp inflammation studies (human or animal not specified in abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:04.648126+00:00"}
{"study_id": 101597, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the pathogenic role of Advanced Glycation End Products (AGEs) in age-related diseases, focusing on kidney, heart, and brain, and to explore potential anti-AGE strategies.", "results_summary": "The study highlights strong connections between AGEs and age-related diseases like chronic kidney disease, heart dysfunction, and neurodegenerative diseases, but notes that causal links still need validation. It also discusses promising anti-AGE strategies under investigation.", "population_specificity": "General focus on age-related diseases in kidney, heart, and brain, without specifying a particular demographic.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:05.027416+00:00"}
{"study_id": 101598, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to investigate the feasibility of using biomarkers (IL-8 and PARK7) as predictors of acute lung injury (ALI) in patients with severe sepsis/septic shock.", "results_summary": "Elevated serum IL-8 and PARK7 levels were significantly associated with a higher risk of developing ALI in patients with severe sepsis/septic shock. Combining serum biomarkers with clinical prediction scores improved the identification of patients vulnerable to ALI.", "population_specificity": "Patients with severe sepsis/septic shock presenting to the emergency department (n = 172).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:06.009041+00:00"}
{"study_id": 101599, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review mechanisms of AGE formation in diabetes and diabetic complications, as well as therapeutic approaches to interfere with AGE formation.", "results_summary": "The abstract highlights that AGE formation is enhanced in diabetes and linked to complications, discusses detoxification pathways like the glyoxalase system, and presents therapeutic strategies to target AGE formation.", "population_specificity": "Diabetes patients and those with diabetic complications (not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:06.910889+00:00"}
{"study_id": 101600, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) and their interaction with RAGE in the pathogenesis and progression of osteoarthritis (OA).", "results_summary": "The study found that AGEs interact with RAGE to increase local inflammation and contribute to cartilage degradation in OA, alongside other DAMPs like HMGB-1 and alarmin proteins. Targeting these DAMPs, including AGEs, may offer potential therapeutic strategies for OA treatment.", "population_specificity": "Adults with osteoarthritis, particularly affecting knee and hip joints.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:08.849459+00:00"}
{"study_id": 101601, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the involvement of the receptor for advanced glycation end-products (RAGE) in the pathogenesis of myasthenia gravis.", "results_summary": "The study found that RAGE expression was more significant in thymoma type B2 and in cases with a shorter duration of myasthenia, suggesting its involvement in the disease's pathophysiology, particularly at onset and in thymoma-associated forms.", "population_specificity": "41 patients with myasthenia gravis (18 men, 23 women, average age 36.44\u00b114.47 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:11.060229+00:00"}
{"study_id": 101602, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify gaps in current knowledge about the role of Advanced Glycation End Products (AGEs) in altered immunity during TB-DM co-occurrence and explore underlying molecular mechanisms.", "results_summary": "The study suggests that excess AGEs and their receptor signaling, along with oxidative stress and epigenetic changes, may contribute to altered immunity in TB-DM patients, but it does not provide specific efficacy or safety data on AGEs.", "population_specificity": "Patients with type 2 diabetes (DM), pre-DM, or no DM, and those with latent or active TB.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:12.046034+00:00"}
{"study_id": 101603, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the role of Advanced Glycation End Products in neuroinflammation and explore the potential of nutraceuticals like polyphenols in preventing and treating Alzheimer's disease.", "results_summary": "The study suggests that Advanced Glycation End Products contribute to neuroinflammation and age-related cognitive decline, while polyphenolic compounds like curcumin and resveratrol may modulate P-glycoprotein to offer therapeutic benefits for Alzheimer's disease.", "population_specificity": "Not specified (general focus on aging and neurodegenerative diseases like Alzheimer's).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:13.357212+00:00"}
{"study_id": 101605, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review epidemiological data on dicarbonyls and advanced glycation end products (AGEs) in association with type 1 and type 2 diabetes to explore alternative pathophysiological pathways for individualized treatments.", "results_summary": "The abstract suggests that hyperglycemia only partially explains diabetic complications, and intensive glucose control has limited impact. It highlights dicarbonyl metabolism and AGE accumulation as potential pathways requiring further investigation for better diabetes management.", "population_specificity": "Patients with type 1 and type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:14.302128+00:00"}
{"study_id": 101606, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze the role of Advanced Glycation End Products (AGEs) in diabetic corneal abnormalities and explore emerging treatments targeting AGEs.", "results_summary": "The study highlights AGEs as contributors to diabetic corneal complications, including delayed wound healing and structural changes, and discusses experimental therapeutics like AGE inhibitors as potential treatments.", "population_specificity": "Patients with type 1 and type 2 diabetes mellitus experiencing corneal abnormalities.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:15.154875+00:00"}
{"study_id": 101604, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether circulating irisin levels correlate with skin autofluorescence values (a measure of Advanced Glycation End Products) in type 2 diabetes patients.", "results_summary": "The study found that circulating irisin levels were significantly lower, while skin autofluorescence values (AGEs) were higher in type 2 diabetes patients compared to healthy controls. This suggests a potential link between irisin levels and AGE accumulation in diabetic patients.", "population_specificity": "362 Chinese type 2 diabetic patients and 100 age- and sex-matched healthy controls.", "effective_dosage": "Not available", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:15.230128+00:00"}
{"study_id": 101607, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in promoting myocardial inflammation and their contribution to diabetic cardiomyopathy.", "results_summary": "The abstract indicates that AGEs are strong triggers for inflammation in the diabetic heart, contributing to cardiac hypertrophy, fibrosis, and dysfunction. These inflammatory processes are linked to the development of diabetic cardiomyopathy through specific intracellular signaling mechanisms.", "population_specificity": "Diabetic individuals with or at risk of heart failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:16.537418+00:00"}
{"study_id": 101608, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand the mechanisms by which Advanced Glycation End Products (AGEs) contribute to diabetic complications and explore strategies to disrupt their formation or action.", "results_summary": "The study found that AGEs contribute to oxidative stress, vascular stiffness, and inflammation, exacerbating diabetic complications. It also highlighted the role of AGEs in activating RAGEs, which amplify pro-inflammatory and pro-sclerotic cytokines.", "population_specificity": "Diabetic patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:17.440960+00:00"}
{"study_id": 101609, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the role of umbilical cord-derived mesenchymal stem cells (MSCs) in clearing advanced glycation end products (AGEs) to improve diabetic wound healing.", "results_summary": "The study suggests that MSCs may enhance autophagy, which could help remove AGEs and improve diabetic wound healing, offering potential clinical applications. However, the exact mechanisms remain unclear.", "population_specificity": "Diabetic wound healing (specific population details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:19.270562+00:00"}
{"study_id": 101610, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of diet, including potential influences like Advanced Glycation End Products, in the pathogenesis and progression of chronic kidney disease (CKD).", "results_summary": "The abstract discusses the potential of dietary modifications, such as protein and sodium restriction, to influence kidney health and reduce CKD burden, but does not specifically address Advanced Glycation End Products.", "population_specificity": "High-risk individuals, such as patients with diabetes, susceptible to CKD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:20.806113+00:00"}
{"study_id": 101611, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the causes of glycation in therapeutic antibodies during manufacturing, storage, and circulation, and to evaluate analytical methods for detecting glycation and AGEs.", "results_summary": "The abstract discusses glycation's potential impact on protein bioactivity and stability, reviews analytical methods for detecting glycation and AGEs, and notes varying biological effects from no impact to loss of activity.", "population_specificity": "Not specified (focus on therapeutic antibodies).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:22.192358+00:00"}
{"study_id": 101612, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of endoplasmic reticulum (ER) stress, triggered by factors like advanced glycation end products (AGEs), in diabetic nephropathy (DN) progression and explore potential therapeutic targets.", "results_summary": "The study found that AGEs contribute to ER stress and kidney injury in DN, and targeting ER-associated proteins like RTN1A may mitigate maladaptive ER stress and improve DN outcomes.", "population_specificity": "Human and mouse diabetic kidneys.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:22.660336+00:00"}
{"study_id": 101613, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential benefits of plant-based diets, including those lower in advanced glycation end products (AGE), in delaying the progression of diabetic kidney disease (DKD).", "results_summary": "Limited evidence suggests that diets lower in AGE or focused on plant-based foods may help prevent DKD progression, but large-scale trials are needed for more definitive conclusions.", "population_specificity": "Patients with diabetic kidney disease (DKD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:23.455042+00:00"}
{"study_id": 101616, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review current understanding of AGEs formation, their association with macrophages, disease links, and therapeutic strategies, including RAGE inhibition.", "results_summary": "The study found that AGEs and their receptor are implicated in various diseases, including diabetes, atherosclerosis, and degenerative conditions. Anti-inflammatory molecules inhibiting AGEs show promise for treating diabetic complications and degenerative diseases.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:26.126752+00:00"}
{"study_id": 101614, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in chronic diseases, particularly their association with sarcopenia, cognitive impairment, and diabetes-related complications.", "results_summary": "The study found that AGEs, generated by chronic hyperglycemia, are present in postmortem Alzheimer's disease brains and are linked to impaired neurogenesis and cognitive decline. Interventions like intranasal insulin and exercise showed potential neuroprotective effects and reversibility of sarcopenia.", "population_specificity": "Adults with chronic diseases, particularly those with diabetes and age-related sarcopenia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:26.275455+00:00"}
{"study_id": 101615, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether diets with different fat quantity and quality affect AGE metabolism in patients with metabolic syndrome (MetS).", "results_summary": "The HMUFA diet reduced serum AGE levels and RAGE mRNA while increasing AGER1 and GloxI mRNA levels. The LFHCC n-3 diet also reduced serum AGE levels and increased AGER1 mRNA, suggesting dietary modulation of AGE metabolism may help reduce MetS-related risks.", "population_specificity": "75 patients with metabolic syndrome (MetS).", "effective_dosage": "Not specified (dietary interventions only).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:26.355810+00:00"}
{"study_id": 101618, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical relevance of skin autofluorescence (SAF) as a biomarker for advanced glycation end products (AGEs) and discuss potential confounding factors affecting its measurement.", "results_summary": "The study found that SAF is a promising biomarker for cumulative skin AGEs and may better predict chronic complications and mortality in diabetes than glycated haemoglobin A1c, but highlighted confounding factors like skin pigmentation and fluorophores that need further analysis.", "population_specificity": "Not specified (general discussion, likely diabetic patients or at-risk populations).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:30.258828+00:00"}
{"study_id": 101617, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanistic links between Type 2 diabetes (T2D) and Alzheimer's disease (AD), focusing on the role of advanced glycation end-products (AGEs) in cognitive decline and AD risk.", "results_summary": "The study found that AGEs, along with impaired insulin signaling, inflammation, and oxidative stress, play a significant role in the pathogenesis of both AD and diabetic complications, suggesting these pathways contribute to increased dementia risk in T2D patients. Early diagnosis of cognitive impairment and identifying high-risk patients are highlighted as challenges for personalized diabetes care.", "population_specificity": "Individuals with Type 2 diabetes mellitus (T2D) and potential risk for Alzheimer's disease (AD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:30.712929+00:00"}
{"study_id": 101619, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products in diabetic microangiopathy, particularly their involvement in oxidative stress, hyperosmolar stress, and inflammatory pathway activation.", "results_summary": "The study identified Advanced Glycation End Products as contributors to oxidative and hyperosmolar stress, as well as inflammatory pathway activation, which impair microcirculation in diabetes. However, the exact mechanisms remain unclear.", "population_specificity": "Individuals with diabetic microangiopathy, including retinopathy.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:30.813664+00:00"}
{"study_id": 101620, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate dietary corrections and foods that may delay or hinder the onset and progression of diabetic nephropathy (DN), with a focus on glycotoxins and micronutrients.", "results_summary": "The study highlights the potential of dietary adjustments, including protein source and glycotoxin content, as well as specific micronutrients, in preventing DN progression. Few clinical trials have specifically addressed these micronutrients, but research on their mechanisms appears promising for nutritional interventions.", "population_specificity": "Patients at risk of or with diabetic nephropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:32.075745+00:00"}
{"study_id": 101621, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of S100A12 in immune responses, particularly its antimicrobial activity against Mycobacterium leprae and its interaction with RAGE and TLR4.", "results_summary": "The study found that S100A12 exhibits antimicrobial activity against Mycobacterium leprae in human macrophages and plays a proinflammatory role via interactions with RAGE and TLR4, suggesting its potential in therapeutic immunity modulation.", "population_specificity": "Human macrophages (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:32.576662+00:00"}
{"study_id": 101623, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the potential of HMGB1 and RAGE as biomarkers for prognosis and risk stratification in heart failure patients.", "results_summary": "The study found a statistically significant positive correlation between RAGE levels and heart failure severity, as indicated by increasing NYHA functional class. HMGB1 correlations were less studied but showed potential as a prognostic biomarker.", "population_specificity": "2025 heart failure patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:34.154885+00:00"}
{"study_id": 101624, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of phlorotannins from brown seaweeds in managing type 2 diabetes by targeting various pharmacological mechanisms.", "results_summary": "The review highlights phlorotannins' effects on pancreatic, hepatic, and intestinal enzymes, glucose transport and metabolism, glucose-induced toxicity, and \u03b2-cell cytoprotection, supported by in vitro and in vivo studies.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:34.606370+00:00"}
{"study_id": 101622, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in diabetic kidney disease (DKD) progression and their potential as therapeutic targets.", "results_summary": "The study suggests AGEs contribute to metabolic memory in DKD progression, alongside other epigenetic mechanisms like DNA methylation and histone modifications. Hypoxia and oxidative stress, influenced by AGEs, are identified as key therapeutic targets, with ongoing trials evaluating interventions like prolyl hydroxylase domain inhibitors and bardoxolone methyl.", "population_specificity": "Patients with diabetic kidney disease (DKD) and chronic kidney disease (CKD) with or without diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:36.117068+00:00"}
{"study_id": 101626, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of the RAGE axis in chronic diseases and evaluate therapeutic opportunities targeting this pathway.", "results_summary": "The study found that RAGE ligands accumulate in chronic diseases, particularly those involving inflammation and metabolic dysfunction, and that targeting the RAGE axis may mitigate disease progression. The interaction between RAGE and DIAPH1 was identified as crucial for signal transduction.", "population_specificity": "Human subjects and animal models with chronic diseases (e.g., autoimmunity, obesity, diabetes, neurodegeneration).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:39.686012+00:00"}
{"study_id": 101627, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (RAGE) in the prothrombotic and proinflammatory effects of inorganic polyphosphate (PolyP) on endothelial cells.", "results_summary": "The study found that PolyP activates the NF-\u03baB signaling pathway, increases cell surface adhesion molecules, and disrupts vascular barrier integrity via RAGE and P2Y receptors, with mTORC1 and mTORC2 pathways regulating these effects.", "population_specificity": "Endothelial cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:40.016136+00:00"}
{"study_id": 101625, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the clinical relevance of RAGE and HMGB1 as potential prognostic markers or therapeutic targets in melanoma, BCC, and SCC.", "results_summary": "RAGE was up-regulated in SCC and melanoma, with higher levels in stage IV melanomas, while lower soluble RAGE levels were linked to poor survival. HMGB1 showed sporadic expression in BCC and SCC and was elevated in non-responders to ipilimumab, suggesting its prognostic value.", "population_specificity": "Patients with cutaneous malignancies (melanoma, BCC, SCC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:40.156774+00:00"}
{"study_id": 101628, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the mechanisms by which Advanced Glycation End Products (AGEs) contribute to oxidative stress and diabetic cardiovascular disease (CVD) and evaluate potential therapeutic approaches to reduce ROS production.", "results_summary": "The study found that AGEs interact with RAGE to promote ROS synthesis, leading to oxidative stress, inflammation, fibrosis, and cardiac dysfunction in diabetic CVD. Anti-oxidant therapies targeting ROS production were considered for potential protective effects against diabetic cardiomyopathy.", "population_specificity": "Diabetic individuals with cardiovascular complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:41.222003+00:00"}
{"study_id": 101629, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of aldose reductase (AR) activation in diabetic nephropathy (DN), including its contribution to advanced glycation end products (AGE) formation and potential therapeutic benefits of AR inhibition.", "results_summary": "The abstract highlights that AR activation in DN leads to oxidative stress, protein kinase c activation, and AGE production, contributing to kidney damage. It summarizes the potential therapeutic benefits of AR inhibition but does not provide specific results on AGE effects.", "population_specificity": "Patients with diabetic nephropathy (a complication of diabetes mellitus).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:42.428381+00:00"}
{"study_id": 101630, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if atorvastatin protects podocytes and proximal tubules in patients with Type 2 diabetes, potentially mitigating early-stage diabetic nephropathy.", "results_summary": "Atorvastatin significantly reduced podocyturia, urinary nephrin, and urinary vascular endothelial growth factor, indicating favorable kidney effects and a correlation between glomerular and proximal tubule dysfunction in early diabetic nephropathy.", "population_specificity": "63 patients with Type 2 diabetes", "effective_dosage": "Equipotent dose of atorvastatin (specific amount not stated)", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:42.896773+00:00"}
{"study_id": 101631, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the scientific evidence supporting the use of blood circulation activating drugs in TCM for preventing and treating DM-induced microvascular complications, including their effects on AGEs.", "results_summary": "The study summarized TCM's effects on improving blood rheology, inhibiting platelet aggregation, reducing AGE formation, regulating oxidative stress, and improving lipid metabolism, providing a theoretical basis for clinical practice.", "population_specificity": "Patients with diabetes mellitus (DM) and its microvascular complications (diabetic nephropathy, diabetic peripheral neuropathy, diabetic retinopathy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:43.573859+00:00"}
{"study_id": 101632, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether plasma levels of soluble RAGE (sRAGE) could predict clinical outcomes after radiofrequency catheter ablation for atrial fibrillation (AF), particularly in diabetic patients.", "results_summary": "Higher plasma sRAGE levels were associated with lower AF recurrence after ablation in diabetic patients, especially those with paroxysmal AF, but no such association was found in non-diabetics.", "population_specificity": "496 patients (142 with diabetes, 354 without) who underwent AF ablation, matched by age, sex, and AF type.", "effective_dosage": "Not specified (measured pre-procedural plasma sRAGE levels).", "study_duration": "Follow-up period of 24.5 \u00b1 18.0 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:46.518324+00:00"}
{"study_id": 101634, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in stimulating VEGF production in the diabetic retina and their contribution to diabetic retinopathy progression.", "results_summary": "The abstract indicates that AGEs, along with hyperglycemia, oxidants, and inflammation, stimulate VEGF production in both hypoxic and pre-hypoxic diabetic retinas, potentially exacerbating retinal damage. Excessive VEGF production in early diabetic retinas may lead to mechanisms that worsen further damage.", "population_specificity": "Diabetic retina (pre-hypoxic and hypoxic states)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:49.600387+00:00"}
{"study_id": 101633, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Advanced Glycation End Products (AGEs) as a clinical biomarker for patients with peripheral artery disease (PAD).", "results_summary": "The abstract discusses the formation and effects of AGEs, methods to measure them, and reviews emerging evidence suggesting AGEs could serve as a biomarker for PAD patients. Several studies on AGEs in PAD are mentioned, but specific efficacy results are not detailed.", "population_specificity": "Patients with peripheral artery disease (PAD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:49.760951+00:00"}
{"study_id": 101635, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare mechanical and biochemical alterations in aortic stenosis (AS) and regurgitation (AR) to understand their pathogenesis, including the role of advanced glycation end-products (AGEs).", "results_summary": "The study found that AGEs were weakly stained in AS but strongly present in AR fibrosa, suggesting different pathological mechanisms\u2014dynamic tissue remodeling in AS versus static chemical alterations in AR.", "population_specificity": "Human aortic valve tissues from AS, AR, and normal groups.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:50.383554+00:00"}
{"study_id": 101636, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in diabetic bone disease, focusing on their impact on bone microstructure and fracture risk.", "results_summary": "The study found that AGEs contribute to skeletal fragility in diabetes by altering bone quality, particularly through increased cortical porosity and matrix changes, alongside low bone turnover. These effects are distinct from typical osteoporosis and complicate fracture risk in type 2 diabetes.", "population_specificity": "Patients with type 1 (T1D) and type 2 diabetes (T2D).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:50.609557+00:00"}
{"study_id": 101638, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) in bone quality and fracture risk in diabetic patients, focusing on their physical and biological mechanisms.", "results_summary": "The study found that AGEs accumulate in bone collagen fibers, affecting bone material properties, and act as agonists for RAGE, suppressing bone metabolism. Concentrations of AGEs and endogenous secretory RAGE were associated with fracture risk independently of bone mineral density.", "population_specificity": "Diabetic patients with elevated fracture risk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:51.739037+00:00"}
{"study_id": 101637, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) and their receptor RAGE in cardiovascular diseases (CVD) and explore therapeutic interventions to mitigate AGE-RAGE-mediated CVD.", "results_summary": "The study found that AGE-RAGE interaction contributes to cardiovascular diseases by generating oxidative stress and inflammation. Therapeutic strategies like reducing AGE consumption, suppressing RAGE, and increasing soluble RAGE (sRAGE) levels showed potential in attenuating CVD.", "population_specificity": "Not specified (general discussion of AGE-RAGE mechanisms and interventions).", "effective_dosage": "Not specified (general dietary and pharmacological interventions mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:52.408871+00:00"}
{"study_id": 101639, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of a low advanced glycation end products (dAGEs) diet versus a standard dAGEs diet on lipid profile, inflammation, and cardiovascular risk in prediabetic subjects.", "results_summary": "The low dAGEs diet significantly improved lipid profiles (reducing total cholesterol, apolipoprotein B, and LDL), reduced inflammation (lowered high-sensitivity C-reactive protein), and decreased intima-media thickness compared to the standard diet. No significant changes were observed in arterial stiffness or endogenous secretory receptor for AGEs levels.", "population_specificity": "62 prediabetic subjects", "effective_dosage": "Not specified", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:54.980705+00:00"}
{"study_id": 101640, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of drugs targeting \u03b2-amyloid (A\u03b2) peptide and tau protein, including an inhibitor of the receptor for advanced glycation end products (RAGE), as disease-modifying treatments for Alzheimer's disease.", "results_summary": "The study reviewed Phase III clinical trials of emerging anti-A\u03b2 drugs, including azeliragon (a RAGE inhibitor), but noted substantial risk of failure due to previous clinical setbacks and incomplete understanding of A\u03b2's role in Alzheimer's disease. The drugs were tested in early-stage AD patients, preclinical familial AD subjects, or high-risk asymptomatic individuals.", "population_specificity": "Subjects in early phases of Alzheimer's disease, preclinical familial AD, or asymptomatic individuals at high risk of developing AD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:57.855539+00:00"}
{"study_id": 101641, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of selenium supplementation on biomarkers of inflammation and oxidative stress, including Advanced Glycation End Products (AGE), in patients with diabetic nephropathy.", "results_summary": "The study found that selenium supplementation did not significantly affect Advanced Glycation End Products (AGE) levels compared to placebo, despite showing favorable effects on other biomarkers like MMP-2, NO, TAC, and GSH.", "population_specificity": "Sixty patients with diabetic nephropathy.", "effective_dosage": "200 \u00b5g/d Se supplements as Se yeast.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:58.688532+00:00"}
{"study_id": 101643, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess whether inhaled sevoflurane improves gas exchange and reduces inflammation in patients with acute respiratory distress syndrome (ARDS).", "results_summary": "The study found that sevoflurane improved oxygenation and reduced levels of epithelial injury markers and some inflammatory markers compared to midazolam in ARDS patients.", "population_specificity": "Adult patients with moderate-to-severe ARDS within 24 hours of onset.", "effective_dosage": "Not specified (inhaled sevoflurane for sedation).", "study_duration": "48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:59.159029+00:00"}
{"study_id": 101642, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the gut-kidney axis and their contribution to uremic toxicity and chronic kidney disease (CKD) progression.", "results_summary": "The study found that AGEs, along with other microbiome products, become toxic when kidneys fail to clear them, exacerbating uremia and CKD progression. It also discussed potential therapeutic interventions targeting the gut microbiome in CKD.", "population_specificity": "Patients with chronic kidney disease (CKD).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:13:59.378384+00:00"}
{"study_id": 101644, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to examine associations between advanced glycation end products (AGEs) and renal function loss (RFL) in American Indians with type 2 diabetes, including structural determinants.", "results_summary": "The study measured five AGEs in serum and assessed their relationship with a \u226540% decline in glomerular filtration rate (GFR) over 6 years, with kidney biopsies performed at the end of the trial. Results suggest an association between AGEs and renal function loss, though specific outcomes are not detailed in the abstract.", "population_specificity": "American Indians with type 2 diabetes (mean baseline age 41 years).", "effective_dosage": "Not specified", "study_duration": "6 years (including post-trial observation)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:01.029440+00:00"}
{"study_id": 101646, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of immune and inflammatory mediators, including Advanced Glycation End Products, in the pathogenesis of diabetic kidney disease (DKD) and explore novel treatment approaches.", "results_summary": "The study identified Advanced Glycation End Products as one of the inflammatory molecules targeted by evolving treatment approaches for DKD, suggesting their involvement in disease progression. However, specific efficacy data on Advanced Glycation End Products were not detailed in the abstract.", "population_specificity": "Patients with diabetic kidney disease (DKD).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:01.829015+00:00"}
{"study_id": 101645, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress, including Advanced Glycation End Products, in patients with diabetic nephropathy.", "results_summary": "Vitamin E supplementation significantly reduced Advanced Glycation End Products levels (-1832.2 \u00b1 1941.6 vs +177.3 \u00b1 324.1 arbitrary units, P < .001) along with other biomarkers of inflammation and oxidative stress, demonstrating favorable effects.", "population_specificity": "60 patients with diabetic nephropathy (30 in the vitamin E group, 30 in the placebo group).", "effective_dosage": "1200 IU/d of vitamin E supplements.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:02.496266+00:00"}
{"study_id": 101647, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the pathological role of the AGEs-RAGE axis in cardiovascular disease (CVD) and its potential as a marker for diabetic macrovascular complications.", "results_summary": "The study found that AGEs accumulate under hyperglycemic conditions and interact with RAGE, contributing to CVD pathogenesis. AGEs may serve as a marker for cumulative diabetic exposure and metabolic memory.", "population_specificity": "Diabetic individuals with potential cardiovascular complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:03.372089+00:00"}
{"study_id": 101649, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to discuss the impact of Advanced Glycation End Products on tendon function in individuals with diabetes and provide evidence-based rehabilitation considerations for tendon pathologies.", "results_summary": "The study highlights that diabetes-induced accumulation of Advanced Glycation End Products negatively affects tendon function, vascularity, and healing, necessitating modified rehabilitation approaches for tendinopathies in diabetic patients.", "population_specificity": "Individuals with diabetes mellitus experiencing tendon pathologies.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:06.951630+00:00"}
{"study_id": 101648, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the clinical significance of sRAGE (soluble receptor for advanced glycation end-products) and S100A12 in predicting the extent of lung involvement in pulmonary tuberculosis (PTB) patients.", "results_summary": "PTB patients had decreased serum sRAGE levels compared to healthy controls. While sRAGE was not highlighted as a primary predictor, S100A12 (a related marker) showed significant associations with disease occurrence and lung alveolar infiltration.", "population_specificity": "119 newly diagnosed, treatment-na\u00efve, sputum smear-positive, HIV-negative PTB patients and 163 healthy controls in India.", "effective_dosage": "Not specified", "study_duration": "6 months (follow-up period)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:08.201160+00:00"}
{"study_id": 101650, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in tendon damage, particularly in the context of obesity-related metabolic disorders.", "results_summary": "The study found that high glucose levels increase AGE formation, which forms stable covalent cross-links within collagen fibers, altering tendon structure and functionality. Obesity and associated metabolic disorders exacerbate this process, contributing to tendon damage.", "population_specificity": "Individuals with obesity, metabolic disorders (e.g., diabetes, impaired glucose tolerance, dyslipidemia), and those engaging in intense physical activity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:08.964773+00:00"}
{"study_id": 101651, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of HMGB1 and its interaction with the receptor for advanced glycation end products in stroke models and its potential as a therapeutic target.", "results_summary": "The abstract highlights that HMGB1, which interacts with the receptor for advanced glycation end products, has biphasic biological properties\u2014contributing to early inflammation after brain injury but also mediating beneficial effects during stroke recovery, possibly due to redox modifications of its cysteine residues.", "population_specificity": "Stroke models (not specified if human or animal).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:09.256350+00:00"}
{"study_id": 101653, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of genistein on Advanced Glycation End Products (AGEs), particularly its ability to trap AGEs and alter the Maillard reaction pathway.", "results_summary": "Genistein altered the Maillard reaction pathway by trapping AGEs in both biological and protein-lactose suspensions, suggesting potential benefits in reducing AGE-related damage. The study also highlighted genistein's broader antioxidant, anticancer, and anti-inflammatory effects.", "population_specificity": "Mice and humans (specific populations not detailed beyond general references).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:11.375409+00:00"}
{"study_id": 101652, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to review the role of the RAGE/NF-\u03baB signaling pathway in Alzheimer's Disease (AD), focusing on its potential detrimental effects and unexpected reparative mechanisms, such as promoting adult neurogenesis.", "results_summary": "The study found that while RAGE/NF-\u03baB activation is linked to neuroinflammation and neurodegeneration in AD, it also has a proneurogenic effect, potentially aiding reparative mechanisms. This effect can be induced by molecules like A\u03b2 oligomers and HMGB-1, which are typically considered toxic.", "population_specificity": "Alzheimer's Disease (AD) brain tissue and related cell phenotypes (neurons and glia).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:11.935967+00:00"}
{"study_id": 101654, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of S100B and its interaction with the receptor of advanced glycation end products in the pathogenic process of subarachnoid hemorrhage (SAH).", "results_summary": "The study suggests that S100B, through its interaction with the receptor of advanced glycation end products, may contribute to oxidative stress and neuroinflammation after SAH, potentially influencing cerebral vasospasm and brain damage. Blood levels of S100B could serve as a biomarker for SAH progression or prognosis.", "population_specificity": "Patients with subarachnoid hemorrhage (SAH).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:12.835536+00:00"}
{"study_id": 101655, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to clarify the relationship between Advanced Glycation End Products (AGEs) structures and diseases using immunochemical techniques and epitope-identified antibodies.", "results_summary": "The study demonstrated progress in understanding AGE involvement in age-related diseases through immunochemical methods but noted unclear relationships between AGE structures and diseases due to limited knowledge of anti-AGE antibody epitopes. The development of epitope-identified antibodies has improved the ability to identify disease-related AGE structures.", "population_specificity": "Not specified (general discussion of AGEs in pathological conditions and clinical samples).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:13.298223+00:00"}
{"study_id": 101656, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between metabolic syndrome-related pathologies, including Advanced Glycation End Products (AGEs), and their impact on the ubiquitin-proteasomal system (UPS).", "results_summary": "The abstract highlights that metabolic dysregulation, including AGE formation, affects the redox-regulated UPS, but experimental data directly linking glucotoxic/lipotoxic stress to UPS changes are limited. It suggests UPS dysfunction may underlie many metabolic syndrome-related pathologies, pointing to potential therapeutic targets.", "population_specificity": "Not specified (focus on cellular mechanisms, not a specific human or animal population).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:16.697161+00:00"}
{"study_id": 101657, "supplement_id": 857, "safety_score": "30", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the pathogenesis of polycystic ovary syndrome (PCOS) and their potential impact on metabolic and reproductive health.", "results_summary": "The study found that high dietary AGEs intake worsens biological effects in women with PCOS, while AGEs restriction may have beneficial health impacts. AGEs contribute to chronic inflammation and oxidative stress, linking them to PCOS-related metabolic and reproductive consequences.", "population_specificity": "Women of reproductive age, particularly those with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:18.278125+00:00"}
{"study_id": 101659, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review the biological significance of Advanced Glycation End Products (AGEs), their potential pathogenic role in chronic diseases like diabetes, and the efficacy of pharmacological agents targeting the glycation pathway.", "results_summary": "The study found that AGEs may contribute to chronic diseases, particularly diabetes, and that some pharmacological agents (e.g., Alagebrium) show promise in reducing AGE burden, while others (e.g., aminoguanidine) have undesirable side effects.", "population_specificity": "Preclinical models and clinical trials, with a focus on diabetes and its complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:19.071072+00:00"}
{"study_id": 101658, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to explore the association between dietary factors, including Advanced Glycation End Products, and the risk of type 1 diabetes during fetal development, lactation, infancy, and childhood.", "results_summary": "The study suggests that processed foods containing higher amounts of Advanced Glycation End Products may be related to a greater risk of type 1 diabetes, while breast milk and certain nutrients like n-3 fatty acids, vitamins D and E, and zinc may offer protective effects.", "population_specificity": "Fetal period, lactation, infancy, and childhood populations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:19.258494+00:00"}
{"study_id": 101660, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in diabetic retinopathy and identify potential biomarkers in tear fluid for early detection.", "results_summary": "The study found that AGEs accumulate due to high blood glucose levels, contributing to inflammation and diabetic retinopathy. Proteomic analysis of tears identified potential biomarkers linking diabetic retinopathy to impaired wound healing in diabetic keratopathy.", "population_specificity": "Diabetic patients, particularly those with or at risk of diabetic retinopathy.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:20.733433+00:00"}
{"study_id": 101662, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of pattern recognition receptors (PRRs), including receptors for advanced glycation end products (RAGE), in chronic pain and explore their therapeutic potential.", "results_summary": "The study found that aberrant activation of PRRs, including RAGE, may contribute to pathological pain, and targeting these receptors reversed or prevented pain in animal models, suggesting therapeutic potential for chronic pain.", "population_specificity": "Preclinical animal models (not specified further).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:21.517743+00:00"}
{"study_id": 101663, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify asthma subtypes based on circulating biomarkers, including sRAGE, and determine if a systemic inflammatory endotype of asthma exists.", "results_summary": "The study identified an asthma endotype characterized by systemic inflammation, marked by elevated VEGF and leptin and reduced sRAGE levels, associated with more severe symptoms.", "population_specificity": "50 untreated asthma patients recruited from a single academic outpatient clinic.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:21.519614+00:00"}
{"study_id": 101661, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of Advanced Glycation End Products (AGEs) in oxidative stress and diabetes progression, and explore pharmacological interventions targeting ROS in type 2 diabetes.", "results_summary": "The study highlights AGEs as a key contributor to oxidative stress and \u03b2-cell dysfunction in diabetes, suggesting ROS as a potential therapeutic target for diabetes treatment. It summarizes current knowledge on ROS activation and its implications for diabetes management.", "population_specificity": "Not specified (review article, not a clinical study)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:21.781920+00:00"}
{"study_id": 101664, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of iridoids, phytochemicals in plant-based foods, to mitigate the accumulation of Advanced Glycation End Products (AGEs) in the body.", "results_summary": "The study found that iridoids exhibit anti-glycation activities in vitro and in vivo, suggesting they may help slow AGE accumulation. The abstract highlights that dietary inclusion of iridoid-rich foods could be a viable strategy for reducing AGE-related health impacts.", "population_specificity": "Not specified (in vitro and in vivo studies mentioned, but no human population details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:26.543837+00:00"}
{"study_id": 101665, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) and their receptor RAGE in pregnancy complicated by type 1 diabetes, as well as strategies to reduce congenital malformations in offspring.", "results_summary": "The study highlights that AGEs, formed due to hyperglycemia, interact with RAGE or sRAGE, influencing inflammatory responses. Pregnancy increases RAGE levels, potentially exacerbating complications in type 1 diabetic women.", "population_specificity": "Females with type 1 diabetes mellitus (T1DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:27.957761+00:00"}
{"study_id": 101667, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of HMGB1 in neuropathic pain (NPP) and its potential as a therapeutic target, focusing on receptors like RAGE (receptor for advanced glycation end products).", "results_summary": "The abstract highlights that HMGB1 plays a key role in neuroinflammation and NPP progression through receptors including RAGE, suggesting it as a potential therapeutic target for NPP.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:28.303565+00:00"}
{"study_id": 101666, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between sRAGE and esRAGE levels and cardiometabolic risk factors in adolescents, particularly focusing on the impact of obesity.", "results_summary": "The study found that obese adolescents, including those metabolically healthy, had significantly lower sRAGE and esRAGE levels compared to lean counterparts. However, an increasing number of cardiometabolic risk factors did not significantly alter sRAGE, esRAGE, or sVAP-1 levels in either lean or obese subjects.", "population_specificity": "2206 apparently healthy adolescents (51% girls) aged 15-19 years.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:29.607216+00:00"}
{"study_id": 101668, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate thiamine metabolism and its relationship with gestational diabetes mellitus (GDM), focusing on plasma thiamine, erythrocyte thiamine diphosphate (TDP), transketolase (TKT) activity, and genetic variability in thiamine transport regulation.", "results_summary": "The study found lower plasma BMI-adjusted thiamine in women with GDM but higher erythrocyte TDP levels, without differences in TKT activity. Genetic associations were identified between postpartum TKT activity and specific SNPs, suggesting potential thiamine mishandling in GDM.", "population_specificity": "Pregnant women with and without gestational diabetes mellitus (GDM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:30.838690+00:00"}
{"study_id": 101671, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of HMGB1 and its interaction with RAGE (receptor for advanced glycation end-products) in glioma development, progression, and treatment resistance.", "results_summary": "The study found that HMGB1, through binding to RAGE and other receptors, activates signaling pathways influencing glioma cell growth, differentiation, motility, and apoptosis, with potential dual roles in promoting or suppressing tumor growth. It also discusses therapeutic approaches targeting HMGB1 to reduce chemoresistance in glioma cells.", "population_specificity": "Human gliomas (intracranial tumors)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:31.316922+00:00"}
{"study_id": 101669, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the mechanisms, diagnosis, and potential interventions for peritoneal fibrosis, including the role of Advanced Glycation End Products in altering mesothelial cell function.", "results_summary": "The abstract highlights that Advanced Glycation End Products, along with other components of peritoneal dialysis solutions, contribute to peritoneal fibrosis by altering mesothelial cell function and proliferation, but the underlying mechanisms remain unclear. The review discusses potential interventions, including pharmacology and gene therapy, for treating peritoneal fibrosis.", "population_specificity": "Patients undergoing long-term peritoneal dialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T09:14:31.397674+00:00"}
